<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">36691</article-id><article-id pub-id-type="doi">10.7554/eLife.36691</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Advance</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>A cell autonomous torsinA requirement for cholinergic neuron survival and motor control</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-33019"><name><surname>Pappas</surname><given-names>Samuel S</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-6980-2058</contrib-id><email>samuelpa@med.umich.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-108754"><name><surname>Li</surname><given-names>Jay</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-8146-4450</contrib-id><email>jayli@med.umich.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-33713"><name><surname>LeWitt</surname><given-names>Tessa M</given-names></name><email>tlewitt95@gmail.com</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-108753"><name><surname>Kim</surname><given-names>Jeong-Ki</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-0218-1215</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-87759"><name><surname>Monani</surname><given-names>Umrao R</given-names></name><email>um2105@cumc.columbia.edu</email><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-33718"><name><surname>Dauer</surname><given-names>William T</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-1775-7504</contrib-id><email>dauer@med.umich.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution content-type="dept">Department of Neurology</institution><institution>University of Michigan</institution><addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution content-type="dept">Cell and Molecular Biology Program</institution><institution>University of Michigan</institution><addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution content-type="dept">Department of Cell Biology</institution><institution>Columbia University Medical Center</institution><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><aff id="aff4"><label>4</label><institution content-type="dept">Center for Motor Neuron Biology and Disease</institution><institution>Columbia University Medical Center</institution><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><aff id="aff5"><label>5</label><institution content-type="dept">Department of Pathology</institution><institution>Columbia University Medical Center</institution><addr-line><named-content content-type="city">New York</named-content></addr-line><country>United States</country></aff><aff id="aff6"><label>6</label><institution content-type="dept">Department of Cell and Developmental Biology</institution><institution>University of Michigan</institution><addr-line><named-content content-type="city">Ann Arbor</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Ptáček</surname><given-names>Louis J</given-names></name><role>Reviewing Editor</role><aff><institution>University of California, San Francisco</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Zoghbi</surname><given-names>Huda Y</given-names></name><role>Senior Editor</role><aff><institution>Texas Children's Hospital</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>17</day><month>08</month><year>2018</year></pub-date><pub-date pub-type="collection"><year>2018</year></pub-date><volume>7</volume><elocation-id>e36691</elocation-id><history><date date-type="received" iso-8601-date="2018-03-15"><day>15</day><month>03</month><year>2018</year></date><date date-type="accepted" iso-8601-date="2018-08-16"><day>16</day><month>08</month><year>2018</year></date></history><permissions><copyright-statement>© 2018, Pappas et al</copyright-statement><copyright-year>2018</copyright-year><copyright-holder>Pappas et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-36691-v2.pdf"/><related-article ext-link-type="doi" id="ra1" related-article-type="article-reference" xlink:href="10.7554/eLife.08352"/><abstract><object-id pub-id-type="doi">10.7554/eLife.36691.001</object-id><p>Cholinergic dysfunction is strongly implicated in dystonia pathophysiology. Previously (Pappas et al., 2015;4:e08352), we reported that Dlx5/6-Cre mediated forebrain deletion of the DYT1 dystonia protein torsinA (Dlx-CKO) causes abnormal twisting and selective degeneration of dorsal striatal cholinergic interneurons (ChI) (Pappas et al., 2015). A central question raised by that work is whether the ChI loss is cell autonomous or requires torsinA loss from neurons synaptically connected to ChIs. Here, we addressed this question by using ChAT-Cre mice to conditionally delete torsinA from cholinergic neurons (‘ChAT-CKO’). ChAT-CKO mice phenocopy the Dlx-CKO phenotype of selective dorsal striatal ChI loss and identify an essential requirement for torsinA in brainstem and spinal cholinergic neurons. ChAT-CKO mice are tremulous, weak, and exhibit trunk twisting and postural abnormalities. These findings are the first to demonstrate a cell autonomous requirement for torsinA in specific populations of cholinergic neurons, strengthening the connection between torsinA, cholinergic dysfunction and dystonia pathophysiology.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>dystonia</kwd><kwd>cholinergic</kwd><kwd>neurodegeneration</kwd><kwd>DYT1</kwd><kwd>torsinA</kwd><kwd>motor behavior</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000065</institution-id><institution>National Institute of Neurological Disorders and Stroke</institution></institution-wrap></funding-source><award-id>RO1NS077730</award-id><principal-award-recipient><name><surname>Dauer</surname><given-names>William T</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution>Tyler's Hope for a Dystonia Cure</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Dauer</surname><given-names>William T</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>RO1NS057482</award-id><principal-award-recipient><name><surname>Monani</surname><given-names>Umrao R</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R21NS099921</award-id><principal-award-recipient><name><surname>Monani</surname><given-names>Umrao R</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>R56NS104218</award-id><principal-award-recipient><name><surname>Monani</surname><given-names>Umrao R</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Conditional deletion of the DYT1 dystonia protein torsinA causes selective cell autonomous neurodegeneration of striatal and brainstem cholinergic neurons, and severe motor behavioral abnormalities.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Multiple lines of evidence implicate striatal cholinergic dysfunction in dystonia pathophysiology (<xref ref-type="bibr" rid="bib46">Pappas et al., 2015</xref>; <xref ref-type="bibr" rid="bib1">Albin et al., 2003</xref>; <xref ref-type="bibr" rid="bib13">Eskow Jaunarajs et al., 2015</xref>; <xref ref-type="bibr" rid="bib47">Pappas et al., 2014</xref>). The symptoms of DYT1 dystonia, caused by a loss of function mutation in the gene encoding torsinA (<xref ref-type="bibr" rid="bib45">Ozelius et al., 1997</xref>), are reduced by antimuscarinic treatments (<italic>e.g.,</italic> trihexyphenidyl)(<xref ref-type="bibr" rid="bib8">Burke et al., 1986</xref>). Antimuscarinic agents also reduce motor (<xref ref-type="bibr" rid="bib46">Pappas et al., 2015</xref>) and electrophysiological (<xref ref-type="bibr" rid="bib36">Maltese et al., 2014</xref>) abnormalities in DYT1 mouse models. Striatal cholinergic dysfunction is a common feature of multiple DYT1 animal models (<xref ref-type="bibr" rid="bib46">Pappas et al., 2015</xref>; <xref ref-type="bibr" rid="bib38">Martella et al., 2009</xref>; <xref ref-type="bibr" rid="bib56">Pisani et al., 2006</xref>; <xref ref-type="bibr" rid="bib62">Sciamanna et al., 2012a</xref>; <xref ref-type="bibr" rid="bib61">Sciamanna et al., 2012b</xref>), and experimental ablation of striatal cholinergic interneurons (ChI) can lead to abnormal postures (<xref ref-type="bibr" rid="bib22">Kaneko et al., 2000</xref>).</p><p>We demonstrated previously that deletion of torsinA from forebrain GABAergic and cholinergic neurons (using Dlx5/6-cre; ‘Dlx-CKO’) causes highly selective degeneration of dorsal striatal ChI roughly coincident with the juvenile onset of abnormal limb clasping and twisting movements(<xref ref-type="bibr" rid="bib46">Pappas et al., 2015</xref>). Selective ChI abnormalities are also present in postmortem tissue from DYT1 subjects (<xref ref-type="bibr" rid="bib46">Pappas et al., 2015</xref>). Abnormal movements in Dlx-CKO mice are reduced by clinically relevant antimuscarinic treatments, strengthening model therapeutic validity and suggesting shared pathophysiology with human dystonia. This work highlights the importance of elucidating the mechanism of selective ChI loss. A critical first step toward this goal is to determine whether the ChI loss observed in Dlx-CKO mice results from a cell autonomous role of torsinA in these cells or, alternatively, whether loss of torsinA from synaptically connected cells is also required. The major aim of these studies was to address this fundamental question.</p><p>To determine whether torsinA-related ChI loss is cell autonomous, we generated and characterized cholinergic neuron selective conditional torsinA knockout mice (ChAT-CKO). We find that ChAT-CKO mice phenocopy the selective degeneration of dorsal striatal ChI observed in Dlx-CKO mice (basal forebrain neuron numbers are normal in both models). Assessment of non-forebrain cholinergic populations demonstrates that pedunculopontine and laterodorsal tegmental brainstem cholinergic neurons, and spinal motor neurons also require torsinA for survival or normal function. ChAT-CKO mice exhibit severe motor and postural abnormalities that are distinct from Dlx-CKO mice. These findings are the first to establish a cell autonomous requirement for torsinA in ChI, as well as identifying additional vulnerable cholinergic neuron populations. This <italic>in vivo</italic> study fundamentally advances and expands understanding of the requirement of torsinA for normal cholinergic system function, opening new directions for the study of mechanisms contributing to selective neuronal dysfunction in dystonia.</p></sec><sec id="s2" sec-type="results|discussion"><title>Results and discussion</title><p>To determine if ChI neurodegeneration is a cell autonomous effect of torsinA loss, we conditionally deleted torsinA from cholinergic neurons (<italic>Chat-IRES-Cre<sup>+</sup>, Tor1a<sup>Flx/-</sup></italic>; ‘ChAT-CKO’ mice; Cre-recombinase expression occurs before birth and is completely selective for cholinergic neurons; <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref> [<xref ref-type="bibr" rid="bib35">Madisen et al., 2010</xref>]). Unilateral unbiased stereology of ChAT-immunoreactive neurons in the dorsal striatum from 1 year old mice demonstrates a ~ 34% reduction in the number of dorsal striatal ChI in ChAT-CKO mice compared to control mice (<xref ref-type="fig" rid="fig1">Figure 1A,B</xref>). This finding was confirmed in an independent cohort using bilateral unbiased stereology (48% reduction; <xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2A</xref>). The number of striatal non-cholinergic neurons was not different from controls (<xref ref-type="fig" rid="fig1s2">Figure 1—figure supplement 2B,C</xref>), demonstrating that there are no secondary cell loss effects of ChI degeneration, and that torsinA loss of function-mediated neurodegeneration is highly specific. These findings establish a cell autonomous torsinA requirement for ChI survival.</p><fig-group><fig id="fig1" position="float"><object-id pub-id-type="doi">10.7554/eLife.36691.002</object-id><label>Figure 1.</label><caption><title>Conditional cholinergic neuron deletion of torsinA causes cell autonomous loss of striatal cholinergic neurons.</title><p>(<bold>A</bold>) Unilateral stereological quantification of the number of ChAT-positive neurons in the striatum of ChAT-CKO and control mice (One-way ANOVA F<sub>(3,28)</sub> = 3.589, p=0.02, Dunnett’s multiple comparisons test: adjusted p value = 0.049; ‘WT’=<italic>Tor1a</italic><sup>Flx/+</sup>; ‘Cre Control’=ChAT-Cre+, <italic>Tor1a</italic> <sup>Flx/+</sup>; ‘Het Control’=<italic>Tor1 a</italic><sup>Flx/-</sup>; ‘ChAT-CKO’=ChAT-Cre+, <italic>Tor1a</italic><sup>Flx/-</sup>). (<bold>B</bold>) ChAT immunohistochemistry of coronal sections containing dorsal striatum from WT and ChAT-CKO mice (cc = corpus callosum). (<bold>C</bold>) Percent reduction in cell density by striatal quadrant (DL = dorsolateral; DM = dorsomedial, VL = ventrolateral, VM = ventromedial). (<bold>D</bold>) Significant ChI loss is selective for dorsal striatal quadrants. Cell density quantification in control and ChAT-CKO striatal quadrants (Two-way ANOVA main effect of genotype F<sub>(3,112)</sub> = 24.02, p&lt;0.0001; main effect of quadrant F<sub>(3,112)</sub>=8.398, p&lt;0.0001; interaction F<sub>(9,112)</sub>=8.11, p&lt;0.0001. Post-hoc Tukey’s multiple comparisons test). (<bold>E</bold>) Basal forebrain neurons are spared in ChAT-CKO mice. Stereological quantification of P75-immunoreactive basal forebrain cholinergic neurons in the nucleus basalis of meynert (NBM), medial septum/nucleus of the vertical limb of the diagonal band (MS/VDB), and globus pallidus (GP). No differences in the number of cholinergic neurons was observed (NBM, t<sub>(13)</sub>=1.684, p=0.11; MS/VDB, t<sub>(13)</sub>=1.537, p=0.148; GP, t<sub>(13)</sub>=0.5, p=0.625). (<bold>F</bold>) P75 immunohistochemistry of sagittal sections containing basal forebrain cholinergic neuron populations. i.c. = internal capsule, ST = striatum.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-36691-fig1-v2"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.36691.003</object-id><label>Figure 1—figure supplement 1.</label><caption><title>ChAT-Cre is expressed prenatally.</title><p>(Upper panels) ChAT-Cre mice were crossed with Ai14 Cre reporter mice. Offspring were collected immediately after birth, brain sections were generated and observed under epifluorescence microscopy. (Lower panels) adjacent sections costained for torsinA. Scale bar = 50 μm.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-36691-fig1-figsupp1-v2"/></fig><fig id="fig1s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.36691.004</object-id><label>Figure 1—figure supplement 2.</label><caption><title>Independent cohort confirmation of selective striatal cholinergic neuron loss in ChAT-CKO mice.</title><p>(<bold>A</bold>) Bilateral unbiased stereology of ChAT-immunoreactive neurons in the dorsal striatum (t<sub>(12)</sub>=4.42, p=0.0008). (<bold>B</bold>) Unbiased stereology of parvalbumin (PV) immunoreactive neurons in the dorsal striatum (t<sub>9</sub> = 0.699, p=0.50). (<bold>C</bold>) Unbiased stereology of Nissl positive cells in the dorsal striatum (Welch’s t-test; t<sub>7.803</sub>=0.655, p=0.53).</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-36691-fig1-figsupp2-v2"/></fig><fig id="fig1s3" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.36691.005</object-id><label>Figure 1—figure supplement 3.</label><caption><title>ChAT-positive neurons are reduced in a topographic pattern throughout the rostrocaudal extent of the dorsal striatum.</title><p>Significant decreases in ChAT-positive cells were observed in the dorsolateral and dorsomedial segments of the dorsal striatum (dorsolateral striatum, two-way ANOVA main effect of genotype F<sub>(3,156)</sub>=74.77, p&lt;0.0001, main effect of rostrocaudal section, F<sub>(5,156)</sub>=10.07, p&lt;0.0001, no interaction F<sub>(15,156)</sub>=1.204, p=0.273; Dorsomedial striatum main effect of genotype F<sub>(3,156)</sub>=50.01, p&lt;0.0001, main effect of rostrocaudal section, F<sub>(5,156)</sub>=41.81, p&lt;0.0001, no interaction F<sub>(15,156)</sub>=1.646, p=0.067. Post-hoc Tukey’s test was performed for all significant main effects. * represents significant difference between ChAT-CKO mice and all control groups). No significant reductions were observed in the ventral segments of the dorsal striatum (ventrolateral; genotype F<sub>(3,156)</sub>=2.84, p=0.039 [post-hoc Tukey’s test adjusted p=0.129 or higher for all comparisons], rostrocaudal section F<sub>(5,156)</sub>=0.479, p=0.79, interaction F<sub>(15,156)</sub>=0.249, p=0.99. ventromedial; genotype F<sub>(3,156)</sub>= 2.706, p=0.047 [post-hoc Tukey’s test adjusted p=0.107 or higher for all comparisons], rostrocaudal section F<sub>(5,156)</sub>=46.28 p&lt;0.0001, interaction F<sub>(15,156)</sub>=0.672, p=0.80).</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-36691-fig1-figsupp3-v2"/></fig><fig id="fig1s4" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.36691.006</object-id><label>Figure 1—figure supplement 4.</label><caption><title>Time course of torsinA protein loss in dorsal and ventral striatum.</title><p>(<bold>A,B</bold>) TorsinA and ChAT staining in dorsal and ventral striatum brain sections from P0 ChAT-CKO and control mice. (<bold>C</bold>) TorsinA mean fluorescence intensity analysis in dorsal or ventral striatal ChI (Two-way ANOVA main effect of genotype F<sub>1,195</sub>= 85.67, p&lt;0.0001; Region, n.s., F<sub>1,195</sub>=3.301, p=0.07; interaction F<sub>1,195</sub>=21.34, p&lt;0.0001. Sidak’s multiple comparisons test, Dorsal striatum control vs ChAT-CKO, p=0.003, Ventral striatum control vs ChAT-CKO, p&lt;0.0001, ChAT-CKO dorsal striatum vs ventral striatum, p=0.0002; Control dorsal striatum vs ventral striatum, n.s., p=0.199). (<bold>D,E</bold>) Frequency histograms of torsinA mean fluorescence intensity in dorsal (n = 57 control, n = 54 ChAT-CKO neurons) and ventral striatal ChI (n = 52 control, n = 36 ChAT-CKO neurons). Scale bar = 10 µm.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-36691-fig1-figsupp4-v2"/></fig><fig id="fig1s5" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.36691.007</object-id><label>Figure 1—figure supplement 5.</label><caption><title>Time course of torsinA protein loss in basal forebrain.</title><p>(<bold>A</bold>) TorsinA and ChAT staining in basal forebrain brain sections from P0 ChAT-CKO and control mice. (<bold>B</bold>) TorsinA mean fluorescence intensity analysis of control and ChAT-CKO (Welch’s t-test t<sub>138.2</sub>=17.35, p&lt;0.0001) and frequency histograms of torsinA mean fluorescence intensity in basal forebrain cholinergic neurons ChI (n = 91 control, n = 79 ChAT-CKO neurons). Scale bar = 10 µm.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-36691-fig1-figsupp5-v2"/></fig></fig-group><p>ChI cell loss is strikingly selective in Dlx-CKO mice, occurring primarily in the dorsal aspects of the striatum, with approximately six times greater cell loss in the dorsolateral compared to ventromedial striatum (57% vs 9% cell density reduction in Dlx-CKO mice; [<xref ref-type="bibr" rid="bib46">Pappas et al., 2015</xref>]). To examine if the cell autonomous ChI degeneration in ChAT-CKO mice follows a similar subregion-selective pattern, we determined the density of ChAT-immunoreactive neurons in each quadrant of the dorsal striatum (as previously [<xref ref-type="bibr" rid="bib46">Pappas et al., 2015</xref>]). Significant reductions in ChI number were limited to the dorsolateral and dorsomedial segments of the dorsal striatum (72% and 54% cell density reductions in dorsolateral and dorsomedial, vs 12% and −4% in ventrolateral and ventromedial segments; <xref ref-type="fig" rid="fig1">Figure 1C</xref>). This topographic pattern of cell loss was present throughout the entire rostro-caudal extent of the striatum (<xref ref-type="fig" rid="fig1">Figure 1C,D</xref>, <xref ref-type="fig" rid="fig1s3">Figure 1—figure supplement 3</xref>). The dorsolateral selectivity of ChI neuron loss is highly relevant, as the dorsolateral striatum is a key motor circuit node functionally integrated according to topographic inputs, whereas ventromedial striatal neurons are connected in associative and limbic circuits (<xref ref-type="bibr" rid="bib2">Alexander et al., 1986</xref>; <xref ref-type="bibr" rid="bib19">Haber, 2016</xref>; <xref ref-type="bibr" rid="bib49">Parent and Hazrati, 1995</xref>). In contrast, the basal forebrain contains cholinergic projection neurons subserving cognitive and attentional control (<xref ref-type="bibr" rid="bib20">Hasselmo and Sarter, 2011</xref>; <xref ref-type="bibr" rid="bib4">Ballinger et al., 2016</xref>), which do not degenerate in <underline>either</underline> model (<xref ref-type="fig" rid="fig1">Figure 1E,F</xref>). Conditional deletion of torsinA from forebrain cholinergic neurons therefore mimics the region-selective vulnerability observed in Dlx-CKO mice, demonstrating a cell autonomous requirement for torsinA in select cholinergic populations. To determine if differing time courses of torsinA loss (via differing torsinA half lives) contributes to selective vulnerability, we assessed torsinA levels in dorsal vs ventral striatal ChI at P0. Surprisingly, despite uniform prenatal Cre recombinase expression and preferential loss of dorsal ChI, torsinA levels were reduced to a greater extent in ventral ChI (dorsal ChI contained 82% of control torsinA levels, while ventral ChI had ~52% remaining; <xref ref-type="fig" rid="fig1s4">Figure 1—figure supplement 4</xref>). Non-vulnerable basal forebrain cholinergic neurons exhibited 49% of control torsinA immunoreactivity (<xref ref-type="fig" rid="fig1s5">Figure 1—figure supplement 5</xref>). These findings demonstrate that a more rapid loss of torsinA during development does not contribute to the unique vulnerability of dorsal ChI.</p><p>TorsinA deletion is restricted to forebrain structures in Dlx-CKO mice. In contrast, ChAT-CKO mice lack torsinA in all cholinergic neurons throughout the neuraxis, enabling us to assess the impact of torsinA loss in additional cholinergic populations. Unbiased stereology of ChAT-immunoreactive neurons in the brainstem demonstrates significantly fewer cholinergic neurons in the pedunculopontine (PPN) and laterodorsal tegmental (LDT) nuclei in 1 year old Chat-CKO mice (<xref ref-type="fig" rid="fig2">Figure 2A–D</xref>). The PPN and LDT also contain GABAergic, and glutamatergic neurons (<xref ref-type="bibr" rid="bib42">Mena-Segovia, 2016</xref>), which significantly outnumber cholinergic neurons (<xref ref-type="bibr" rid="bib41">Mena-Segovia et al., 2009</xref>; <xref ref-type="bibr" rid="bib71">Wang and Morales, 2009</xref>). Unbiased stereology of NeuN +neurons in PPN and LDT showed no significant change in the overall number of neurons (<xref ref-type="fig" rid="fig2">Figure 2A,C</xref>). Because cholinergic neurons are a minority of cells in the PPN and LDT, it is possible that a significant reduction of this small sub-population cannot be detected when assessed by counting overall NeuN +neuron number. It is also possible that PPN and LDT cholinergic neurons exhibit reduced ChAT expression rather than actual cell loss. Regardless, either possibility demonstrates a cell autonomous role for torsinA for normal function of these cells. These findings also indicate that the loss or dysfunction of brainstem cholinergic neurons does not have deleterious effects on the viability of surrounding neurons. Consistent with this finding, there was no evidence of reactive microgliosis or astrogliosis in the brainstem (<xref ref-type="fig" rid="fig2s1">Figure 2—figure supplement 1</xref>). Quantification of the number of spinal motor neurons (C3-C5; [<xref ref-type="bibr" rid="bib25">Kim et al., 2017</xref>]) demonstrated significantly fewer motor neurons in ChAT-CKO mice (<xref ref-type="fig" rid="fig2">Figure 2E,F</xref>).</p><fig-group><fig id="fig2" position="float"><object-id pub-id-type="doi">10.7554/eLife.36691.008</object-id><label>Figure 2.</label><caption><title>ChAT-CKO mice have significantly fewer brainstem and spinal cord cholinergic neurons.</title><p>(<bold>A,B</bold>) Stereological quantification of ChAT-positive or NeuN-positive neurons in the pedunculopontine nucleus (PPN) of control and ChAT-CKO mice (ChAT; t<sub>(14)</sub>=4.531, p=0.0005. NeuN; t<sub>(14)</sub>=0.095, p=0.92). (<bold>C,D</bold>) Stereological quantification of ChAT-positive or NeuN-positive neurons in the laterdorsal tegmental nucleus (LDT) of control and ChAT-CKO mice (ChAT; t<sub>(14)</sub>=3.571, p=0.003. NeuN; t<sub>(14)</sub>=1.934, p=0.073). (<bold>E,F</bold>) Quantification of the number of ChAT-positive neurons in the cervical spinal cord of control and ChAT-CKO mice (t<sub>(6)</sub>=3.654, p=0.0107). Scale bars = 100 μm.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-36691-fig2-v2"/></fig><fig id="fig2s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.36691.009</object-id><label>Figure 2—figure supplement 1.</label><caption><title>Absence of gliosis in the brainstem of ChAT-CKO mice.</title><p>Immunohistochemistry of GFAP (glial fibrillary acidic protein; specific to astrocytes) and Iba-1 (ionized calcium-binding adapter molecule 1; specific to microglia) in sagittal sections of control and ChAT-CKO hindbrain demonstrate normal distribution of glia.</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-36691-fig2-figsupp1-v2"/></fig></fig-group><p>The identification of cholinergic dysfunction or loss in PPN and LDT is notable, as considerable data implicate these cells in motor and postural control. PPN and LDT cholinergic neurons are distributed in a rostrocaudal continuum in the brainstem, forming a coordinated functional unit (<xref ref-type="bibr" rid="bib42">Mena-Segovia, 2016</xref>; <xref ref-type="bibr" rid="bib40">Mena-Segovia and Bolam, 2017</xref>). PPN and LDT cholinergic neurons topographically innervate the striatum and striatal-projecting thalamic and midbrain dopamine neurons (<xref ref-type="bibr" rid="bib10">Dautan et al., 2014</xref>), such that rostral PPN modulates motor-related circuits, LDT innervates limbic circuits, and caudal PPN targets both regions (<xref ref-type="bibr" rid="bib42">Mena-Segovia, 2016</xref>; <xref ref-type="bibr" rid="bib72">Xiao et al., 2016</xref>) via both direct and indirect inputs. Consistent with a central role in modulating locomotor activity, optogenetic stimulation of PPN cholinergic neurons alters locomotion speed, while stimulation of adjacent glutamatergic neurons induces locomotion (<xref ref-type="bibr" rid="bib72">Xiao et al., 2016</xref>; <xref ref-type="bibr" rid="bib58">Roseberry et al., 2016</xref>; <xref ref-type="bibr" rid="bib9">Capelli et al., 2017</xref>). Cholinergic PPN lesion alone or in combination with dopaminergic denervation impairs gait and causes postural abnormalities in primates (<xref ref-type="bibr" rid="bib16">Grabli et al., 2013</xref>; <xref ref-type="bibr" rid="bib24">Karachi et al., 2010</xref>). In rodents, cholinergic-selective PPN lesion impairs performance on the accelerating rotarod and alters sensorimotor gating (<xref ref-type="bibr" rid="bib33">MacLaren et al., 2014a</xref>; <xref ref-type="bibr" rid="bib34">MacLaren et al., 2014b</xref>), while non-specific PPN ablation alters gait (<xref ref-type="bibr" rid="bib5">Blanco-Lezcano et al., 2017</xref>) and impairs reversal learning (<xref ref-type="bibr" rid="bib67">Syed et al., 2016</xref>). Human neuroimaging and postmortem studies also provide support for a connection between PPN cholinergic integrity and motor function. PPN cholinergic loss is linked to gait abnormalities in Parkinson disease (<xref ref-type="bibr" rid="bib24">Karachi et al., 2010</xref>; <xref ref-type="bibr" rid="bib6">Bohnen et al., 2009</xref>), and brainstem lesions (including PPN loss) can result in complex dystonia (<xref ref-type="bibr" rid="bib21">Jankovic and Patel, 1983</xref>; <xref ref-type="bibr" rid="bib29">LeDoux and Brady, 2003</xref>; <xref ref-type="bibr" rid="bib32">Loher and Krauss, 2009</xref>; <xref ref-type="bibr" rid="bib75">Zweig et al., 1988</xref>; <xref ref-type="bibr" rid="bib43">Mente et al., 2018</xref>). Systematic cholinergic brainstem cell counts have not been performed in DYT1 dystonia postmortem samples; most studies have failed to demonstrate neuronal inclusions or overt cell loss in this region (<xref ref-type="bibr" rid="bib50">Paudel et al., 2014</xref>; <xref ref-type="bibr" rid="bib57">Pratt et al., 2016</xref>; <xref ref-type="bibr" rid="bib39">McNaught et al., 2004</xref>).</p><p>Motor behavior is severely disrupted in ChAT-CKO mice, but is distinct from the Dlx-CKO phenotype (<xref ref-type="fig" rid="fig3">Figure 3</xref>; <xref ref-type="table" rid="table1">Table 1</xref>). ChAT-CKO pups are initially indistinguishable from littermates, but at approximately 4 weeks of age develop a hunched posture, have unkempt fur, and exhibit reduced responsiveness to handling (<xref ref-type="fig" rid="fig3">Figure 3A</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>). Whereas normal mice exhibit a slight dorsal spinal curvature at rest, ChAT-CKO mice exhibit severe kyphosis, including during locomotion (assessed by two observers blind to experimental conditions; <xref ref-type="fig" rid="fig3">Figure 3B</xref>; <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>; <xref ref-type="video" rid="fig3video1">Figure 3—video 1</xref>) (<xref ref-type="bibr" rid="bib18">Guyenet et al., 2010</xref>). ChAT-CKO mice also exhibit signs of weakness, including a significantly reduced ability to hang by the forelimbs (<xref ref-type="fig" rid="fig3">Figure 3C</xref>), tremulous movements, labored breathing (<xref ref-type="video" rid="fig3video1">Figure 3—video 1</xref>), and significantly reduced horizontal and vertical movement in the open field (<xref ref-type="fig" rid="fig3">Figure 3D,E</xref>, <xref ref-type="fig" rid="fig3s2">Figure 3—figure supplement 2</xref>). Remarkably, performance on the accelerating rotarod during two days of training appears normal (<xref ref-type="fig" rid="fig3">Figure 3F</xref>). The normal rotarod behavior differs from models of motor neuron and neuromuscular disease, suggesting that neuromuscular weakness is modest in ChAT-CKO, and less likely to contribute to other behavioral phenotypes (e.g., postural abnormality). The gait of ChAT-CKO mice is also significantly altered (<xref ref-type="fig" rid="fig3">Figure 3G–I</xref>). This constellation of behavioral phenotypes is distinct from Dlx-CKO mice (<xref ref-type="table" rid="table1">Table 1</xref>), in which loss of dorsal striatal ChI is associated with a set of persistent abnormal action-induced motor behaviors, including limb clasping and trunk twisting during tail suspension and open field hyperactivity (<xref ref-type="bibr" rid="bib46">Pappas et al., 2015</xref>). ChAT-CKO mice did not exhibit fore- or hindlimb clasping during tail suspension, but did exhibit tremulousness and trunk twisting (15 CKO, 19 heterozygous, 22 Cre control, and 19 wild type mice observed; <xref ref-type="video" rid="fig3video2">Figure 3—video 2</xref>). These results suggest that dorsal striatal ChI neurodegeneration may not, by itself, be sufficient to cause limb clasping during tail suspension. However, the co-occurrence of brainstem and spinal cord neurodegeneration and tremulousness in ChAT-CKO mice could modify a clasping phenotype and therefore limit this strength of this conclusion.</p><fig-group><fig id="fig3" position="float"><object-id pub-id-type="doi">10.7554/eLife.36691.010</object-id><label>Figure 3.</label><caption><title>Motor behavior is severely disrupted in ChAT-CKO mice.</title><p>(<bold>A</bold>) Representative image of a control and ChAT-CKO mouse demonstrates severe kyphosis and unkempt coat. (<bold>B</bold>) ChAT-CKO mice exhibit significantly increased kyphotic curvature during locomotion (Mann-Whitney U = 35, p&lt;0.0001). (<bold>C</bold>) ChAT-CKO mice exhibit a significantly reduced latency to fall during forelimb suspension (Mann-Whitney U = 71.5, p&lt;0.0001). (<bold>D, E</bold>) ChAT-CKO mice are hypoactive in the open field (horizontal movement, t<sub>(23)</sub>=2.345, p=0.028; vertical rears, welch-corrected t<sub>(15.1)</sub> = 2.345, p=0.033). (<bold>F</bold>) Performance on the accelerated rotarod does not significantly differ from controls (two-way repeated measures ANOVA, genotype, F<sub>(1,43)</sub>=0.75, p=0.389; trial, F<sub>(9,387)</sub>=55.63, p&lt;0.0001; interaction, F<sub>(9,387)</sub>=1.194, p=0.297). (G - I) ChAT-CKO mouse gait is abnormal during locomotion (<italic>paw angle</italic>, two-way ANOVA main effect of genotype, F<sub>(1,56)</sub>=30.54, p&lt;0.0001, main effect of limb F<sub>(3,56)</sub>=51.02, p&lt;0.0001, interaction F<sub>(3,56)</sub>=13.51, p&lt;0.0001, post-hoc Sidak’s multiple comparisons test. <italic>Stance width</italic>, t<sub>(14)</sub>=3.329, p=0.005. <italic>Stride length</italic>, two-way ANOVA genotype F<sub>(1,28)</sub>=3.164, p=0.086, limb F<sub>(1,28)</sub>=0.02, p=0.887, interaction F<sub>(1,28)</sub>=0.0001, p=0.989).</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-36691-fig3-v2"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.36691.011</object-id><label>Figure 3—figure supplement 1.</label><caption><title>Representative examples of control and ChAT-CKO spinal cords demonstrate significant kyphotic curvature.</title></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-36691-fig3-figsupp1-v2"/></fig><fig id="fig3s2" position="float" specific-use="child-fig"><object-id pub-id-type="doi">10.7554/eLife.36691.012</object-id><label>Figure 3—figure supplement 2.</label><caption><title>ChAT-CKO mice are significantly hypoactive.</title><p>(Upper panel) Open field analysis of horizontal movements (two-way repeated measures ANOVA main effect of genotype F<sub>(1,23)</sub>=5.498, p=0.02, time F<sub>(11,253)</sub>=9.222, p&lt;0.0001, interaction F<sub>(11,253)</sub>=0.899, p=0.541, post-hoc Sidak’s multiple comparisons test). (Lower panel) Open field analysis of vertical rearing movements (two-way repeated measures ANOVA main effect of genotype F<sub>(1,23)</sub>=4.413, p=0.046, time F<sub>(11,253)</sub>=2.452, p=0.0063, interaction F<sub>(11,253)</sub>=0.987, p=0.458).</p></caption><graphic mime-subtype="postscript" mimetype="application" xlink:href="elife-36691-fig3-figsupp2-v2"/></fig><media id="fig3video1" mime-subtype="mp4" mimetype="video" xlink:href="elife-36691-fig3-video1.mp4"><object-id pub-id-type="doi">10.7554/eLife.36691.013</object-id><label>Figure 3—video 1.</label><caption><title>Representative video demonstrating tremulousness, kyphosis, and hyperactivity in ChAT-CKO mice, as compared to controls.</title></caption></media><media id="fig3video2" mime-subtype="mp4" mimetype="video" xlink:href="elife-36691-fig3-video2.mp4"><object-id pub-id-type="doi">10.7554/eLife.36691.014</object-id><label>Figure 3—video 2.</label><caption><title>ChAT-CKO exhibit twisting and tremulousness, but not limb clasping during tail suspension.</title><p>Representative video demonstrating tail suspension test in control and ChAT-CKO mice.</p></caption></media></fig-group><table-wrap id="table1" position="float"><object-id pub-id-type="doi">10.7554/eLife.36691.015</object-id><label>Table 1.</label><caption><title>Behavioral properties of Dlx-CKO and ChAT-CKO mice.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom">Motor function</th><th valign="bottom">Dlx-CKO</th><th valign="bottom">ChAT-CKO</th></tr></thead><tbody><tr><td valign="bottom"/><td valign="bottom"><xref ref-type="bibr" rid="bib46">Pappas et al., 2015</xref> eLife 4:e08352</td><td valign="bottom">present manuscript</td></tr><tr><td valign="bottom">Tail suspension</td><td valign="bottom">Trunk twisting</td><td valign="bottom">Trunk twisting</td></tr><tr><td valign="bottom"/><td valign="bottom">Forelimb clasping</td><td valign="bottom">-</td></tr><tr><td valign="bottom"/><td valign="bottom">Hindlimb clasping</td><td valign="bottom">-</td></tr><tr><td valign="bottom"/><td valign="bottom">-</td><td valign="bottom">Tremulousness</td></tr><tr><td valign="bottom">Open field</td><td valign="bottom">Hyperactivity</td><td valign="bottom">Hypoactivity</td></tr><tr><td valign="bottom">Rotarod</td><td valign="bottom">Normal</td><td valign="bottom">Normal</td></tr><tr><td valign="bottom">Response to handling</td><td valign="bottom">Exaggerated</td><td valign="bottom">Reduced</td></tr><tr><td valign="bottom">Weakness, latency to fall</td><td valign="bottom">Grid hang reduction</td><td valign="bottom">Wire hang reduction</td></tr><tr><td valign="bottom">Gait</td><td valign="bottom">Normal by eye</td><td valign="bottom">Abnormal by eye</td></tr><tr><td valign="bottom"/><td valign="bottom">Slightly reduced stance width</td><td valign="bottom">Increased stance width</td></tr><tr><td valign="bottom"/><td valign="bottom">-</td><td valign="bottom">Increased paw angle</td></tr><tr><td valign="bottom">Overt postural abnormalities</td><td valign="bottom">-</td><td valign="bottom">Severe kyphosis</td></tr><tr><td valign="bottom">Tremulous movement</td><td valign="bottom">-</td><td valign="bottom">Severe</td></tr><tr><td valign="bottom">Labored breathing</td><td valign="bottom">-</td><td valign="bottom">Severe</td></tr></tbody></table></table-wrap><p>While no single system or experimental approach can fully model a disease, the extreme postural abnormalities (kyphosis and twisting) in ChAT-CKO mice are reminiscent of Oppenheim’s original description of dystonia (<xref ref-type="bibr" rid="bib26">Klein and Fahn, 2013</xref>), suggesting that a constellation of cholinergic abnormalities may contribute to such a phenotype. The abnormal gait, tremulous movement, weakness, labored breathing, and appearance of reduced muscle mass in ChAT-CKO mice are consistent with brainstem and spinal cord pathology, yet the time course of ChAT-CKO abnormalities (beginning during development) differ from motor neuron and neuromuscular disease models, in which behavioral phenotypes typically emerge in adulthood (9–11 months of age; (<xref ref-type="bibr" rid="bib12">Dickinson and Meikle, 1973</xref>; <xref ref-type="bibr" rid="bib7">Bridges et al., 1992</xref>; <xref ref-type="bibr" rid="bib11">Deconinck et al., 1997</xref>; <xref ref-type="bibr" rid="bib17">Grady et al., 1997</xref>; <xref ref-type="bibr" rid="bib28">Laws and Hoey, 2004</xref>; <xref ref-type="bibr" rid="bib31">Liu et al., 2016</xref>; <xref ref-type="bibr" rid="bib66">Sopher et al., 2004</xref>; <xref ref-type="bibr" rid="bib44">Monks et al., 2007</xref>). Early motor behavioral manifestations also occur in Dlx-CKO and other DYT1 models, emphasizing the importance of torsinA function during development and maturation at behavioral (<xref ref-type="bibr" rid="bib46">Pappas et al., 2015</xref>; <xref ref-type="bibr" rid="bib30">Liang et al., 2014</xref>), cellular (<xref ref-type="bibr" rid="bib48">Pappas et al., 2018</xref>), and molecular levels (<xref ref-type="bibr" rid="bib68">Tanabe et al., 2016</xref>).</p><p>These findings establish a cell autonomous requirement of torsinA for the normal function and survival of distinct populations of cholinergic neurons. Comparison of basic cellular properties between susceptible and invulnerable cholinergic neuron populations does not identify obvious patterns driving selective vulnerability (<xref ref-type="table" rid="table2">Tables 2</xref> and <xref ref-type="table" rid="table3">3</xref>). Within the striatum, dorsal ChI are highly vulnerable to cell death, while ventral ChI are spared. It is unclear whether molecular differences within different ChI populations drive vulnerability, or if differences in connectivity or response to inputs contributes to their loss; these possibilities are not mutually exclusive. While often considered a single neuronal class, an existing and enlarging literature demonstrates that dorsal and ventral striatal ChI exhibit significant differences in morphology, regulation, and receptor expression (reviewed in [<xref ref-type="bibr" rid="bib15">Gonzales and Smith, 2015</xref>]), as well as differing firing patterns during behavioral tasks (<xref ref-type="bibr" rid="bib73">Yarom and Cohen, 2011</xref>) and responses to serotonergic input (<xref ref-type="bibr" rid="bib70">Virk et al., 2016</xref>). These differences implicate the presence of multiple ChI subclasses, though it is important to note that the spared ‘ventral’ population here represents the ventral part of the dorsal striatum, not the nucleus accumbens. Thalamostriatal and corticostriatal input is highly topographic (<xref ref-type="bibr" rid="bib2">Alexander et al., 1986</xref>; <xref ref-type="bibr" rid="bib65">Smith et al., 2004</xref>), raising the possibility that aberrant input from different thalamic nuclei or cortical regions (or aberrant response to that input) could alter the susceptibility of dorsal vs ventral ChI. It is likely that a combination of these and other factors plays a role in the differential susceptibility of cholinergic neuronal populations, including their molecular profiles (e.g., protective factors in some neurons, susceptibility factors in others), the response to afferent inputs, and their inherent physiological properties.</p><table-wrap id="table2" position="float"><object-id pub-id-type="doi">10.7554/eLife.36691.016</object-id><label>Table 2.</label><caption><title>Vulnerability of cholinergic populations.</title><p>(*)=Unconfirmed by independent marker.</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top"/><th colspan="2" valign="top">Cre expression</th><th colspan="2" valign="top">Cell death vulnerability</th></tr><tr><th valign="top">Cholinergic population</th><th valign="top">Dlx-Cre</th><th valign="top">ChAT-Cre</th><th valign="top">Dlx-Cre</th><th valign="top">ChAT-Cre</th></tr></thead><tbody><tr><td valign="top">Dorsolateral striatum <break/>(including dorsal caudate <break/>putamen)</td><td valign="top">Confirmed</td><td valign="top">Confirmed</td><td valign="top">Severe</td><td valign="top">Severe</td></tr><tr><td valign="top">Dorsomedial striatum <break/>(including ventral caudate <break/>putamen)</td><td valign="top">Confirmed</td><td valign="top">Confirmed</td><td valign="top">Mild</td><td valign="top">Spared</td></tr><tr><td valign="top">Nucleus accumbens</td><td valign="top">Confirmed</td><td valign="top">Confirmed</td><td valign="top">-</td><td valign="top">-</td></tr><tr><td valign="top">Basal forebrain</td><td valign="top">Confirmed</td><td valign="top">Confirmed</td><td valign="top">Spared</td><td valign="top">Spared</td></tr><tr><td valign="top">Cholinergic Brainstem</td><td valign="top">Absent</td><td valign="top">Confirmed</td><td valign="top">n/a</td><td valign="top">Severe (*)</td></tr><tr><td valign="top">Primary Motor Neurons</td><td valign="top">Absent</td><td valign="top">Confirmed</td><td valign="top">n/a</td><td valign="top">Moderate</td></tr></tbody></table></table-wrap><table-wrap id="table3" position="float"><object-id pub-id-type="doi">10.7554/eLife.36691.017</object-id><label>Table 3.</label><caption><title>Properties of cholinergic neuronal populations.</title><p>‘Nucleus Basalis Complex’=Nucleus Basalis of Meynert, Horizontal limb of the diagonal band of Broca, Ventral Pallidum, Magnocellular Preoptic Area, Substantia Inominata, Nucleus of the Ansa Lenticularis. ‘Septa”l = Medial Septum, Vertical Limb of the Diagonal Band of Broca. ‘Cholinergic Brainstem’=Pedunculopontine Nucleus, Laterodorsal Tegmental Nucleus (<xref ref-type="bibr" rid="bib46">Pappas et al., 2015</xref>; <xref ref-type="bibr" rid="bib40">Mena-Segovia and Bolam, 2017</xref>; <xref ref-type="bibr" rid="bib15">Gonzales and Smith, 2015</xref>; <xref ref-type="bibr" rid="bib37">Manns et al., 2000</xref>; <xref ref-type="bibr" rid="bib69">Unal et al., 2012</xref>; <xref ref-type="bibr" rid="bib51">Petzold et al., 2015</xref>; <xref ref-type="bibr" rid="bib23">Kanning et al., 2010</xref>; <xref ref-type="bibr" rid="bib27">Kreitzer, 2009</xref>; <xref ref-type="bibr" rid="bib74">Zaborszky et al., 2012</xref>; <xref ref-type="bibr" rid="bib14">Garcia-Rill, 1991</xref>; <xref ref-type="bibr" rid="bib64">Semba et al., 1988</xref>; <xref ref-type="bibr" rid="bib63">Semba and Fibiger, 1992</xref>; <xref ref-type="bibr" rid="bib52">Phelps et al., 1990a</xref>; <xref ref-type="bibr" rid="bib53">Phelps et al., 1988</xref>; <xref ref-type="bibr" rid="bib55">Phelps et al., 1990b</xref>; <xref ref-type="bibr" rid="bib54">Phelps et al., 1989</xref>; <xref ref-type="bibr" rid="bib3">Aroca and Puelles, 2005</xref>; <xref ref-type="bibr" rid="bib60">Schambra et al., 1989</xref>).</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom">Cholinergic population</th><th valign="bottom">Neuronal class</th><th valign="bottom">Firing properties</th><th valign="bottom">Efferent projections</th><th valign="bottom">Afferent inputs</th><th valign="bottom">Birth date/final mitosis</th><th valign="bottom">Embryonic origin</th><th valign="bottom">ChAT expression</th></tr></thead><tbody><tr><td valign="bottom">Dorsolateral striatum (including dorsal caudate putamen)</td><td valign="bottom">Interneuron</td><td valign="bottom">tonically active, 2–10 Hz baseline firing rate</td><td valign="bottom">Local - striatal spiny projection neurons and fast spiking interneurons</td><td valign="bottom">Thalamus, sensorimotor cortex, striatal spiny projection neurons, striatal interneurons</td><td valign="bottom">E12-E15</td><td valign="bottom">MGE</td><td valign="bottom">~E16</td></tr><tr><td valign="bottom">Dorsomedial striatum (including ventral caudate putamen)</td><td valign="bottom">Interneuron</td><td valign="bottom">tonically active, 2–10 Hz baseline firing rate</td><td valign="bottom">Local - striatal spiny projection neurons and fast spiking interneurons</td><td valign="bottom">Thalamus, association cortices, striatal spiny projection neurons, striatal interneurons</td><td valign="bottom">E12-E15</td><td valign="bottom">MGE</td><td valign="bottom">~E16</td></tr><tr><td valign="bottom">Nucleus accumbens</td><td valign="bottom">Interneuron</td><td valign="bottom">tonically active, 0.6–12 Hz baseline firing rate</td><td valign="bottom">Local - striatal spiny projection neurons and fast spiking interneurons</td><td valign="bottom">Thalamus, frontal cortex, striatal spiny projection neurons, striatal interneurons</td><td valign="bottom">E12-E15</td><td valign="bottom">MGE</td><td valign="bottom">~E16</td></tr><tr><td valign="bottom">Basal forebrain</td><td valign="bottom">Projection neuron</td><td valign="bottom">Tonic/burst, subtype dependent</td><td valign="bottom">Cortex (Nucleus Basalis Complex), Hippocampus (Septal)</td><td valign="bottom">Medulla, locus ceruleus, substantia nigra, ventral tegmental area, hypothalamic nuclei, nucleus accumbens, amygdala, local intrinsic GABAergic and glutamatergic collaterals</td><td valign="bottom">E11-E15</td><td valign="bottom">POA/MGE</td><td valign="bottom">~E15-16</td></tr><tr><td valign="bottom">Cholinergic Brainstem</td><td valign="bottom">Projection neuron</td><td valign="bottom">episodic</td><td valign="bottom">Midbrain, superior colliculus, thalamus, globus pallidus, hypothalamus, septum, striatum, cortex</td><td>Brainstem reticular formation, midbrain central gray, lateral hypothalamus-zona incerta, cortex, amygdala, basal forebrain, basal ganglia output nuclei, brainstem and spinal cord sensory nuclei</td><td valign="bottom">E12-E13</td><td valign="bottom">Ventral rhombomere 1 (r1)</td><td valign="bottom"/></tr><tr><td valign="bottom">Primary Motor Neurons</td><td valign="bottom">Projection neuron</td><td valign="bottom">subtype dependent</td><td valign="bottom">Muscle</td><td valign="bottom">Motor Cortex, local spinal cord interneurons and sensory neurons</td><td valign="bottom">E11-E12</td><td valign="bottom">Ventral spinal cord progenitor domains</td><td valign="bottom">E13</td></tr></tbody></table></table-wrap><p>These studies greatly strengthen the connection between torsinA and cholinergic dysfunction, demonstrating that specific cholinergic populations exhibit a cell autonomous selective vulnerability to torsinA deficiency, while others – basal forebrain and ventral striatum – are spared. These findings open novel avenues of study aimed at defining the molecular mechanisms responsible for this cell autonomous selective vulnerability, and circuit-level analyses to ameliorate the effects of cholinergic neurotransmission abnormalities.</p></sec><sec id="s3" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th>Reagent type (species) <break/>or resource</th><th>Designation</th><th>Source or reference</th><th>Identifiers</th><th>Additional information</th></tr></thead><tbody><tr><td>Gene <break/>(Mus musculus)</td><td><italic>Tor1a</italic></td><td>NA</td><td valign="bottom">NCBI Gene: 30931; <break/>MGI:1353568</td><td>Encodes TorsinA</td></tr><tr><td>Strain, strain <break/>background(M. musculus)</td><td>ChAT-Cre</td><td>Jackson Laboratories</td><td>Stock ID 006410</td><td>Chat<sup>tm2(cre)Lowl</sup>; (Chat-IRES-Cre)</td></tr><tr><td>Strain, strain <break/>background(M. musculus)</td><td>Tor1a<sup>Flx/Flx</sup></td><td>Jackson Laboratories</td><td>Stock ID 025832</td><td>Tor1a<sup>tm3.1Wtd</sup></td></tr><tr><td>Strain, strain <break/>background(M. musculus)</td><td valign="bottom">Tor1a<sup>-/-</sup></td><td valign="bottom">Jackson Laboratories</td><td>Stock ID 006251</td><td valign="bottom">Tor1a<sup>tm1Wtd</sup></td></tr><tr><td>Antibody</td><td valign="bottom">Choline <break/>Acetyltransferase</td><td valign="bottom">Millipore AB144P</td><td valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2079751">AB_2079751</ext-link></td><td valign="bottom">1:100</td></tr><tr><td>Antibody</td><td valign="bottom">P75 Neurotrophin <break/>Receptor</td><td valign="bottom">Santa Cruz sc6188</td><td valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2267254">AB_2267254</ext-link></td><td valign="bottom">1:100</td></tr><tr><td>Antibody</td><td valign="bottom">NeuN</td><td valign="bottom">Cell Signaling #12943</td><td valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2630395">AB_2630395</ext-link></td><td valign="bottom">1:500</td></tr><tr><td>Antibody</td><td valign="bottom">GFAP</td><td valign="bottom">Cell Signaling #3670P</td><td valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_561049">AB_561049</ext-link></td><td valign="bottom">1:1000</td></tr><tr><td>Antibody</td><td valign="bottom">Iba-1</td><td valign="bottom">Wako 019–19741</td><td valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_839504">AB_839504</ext-link></td><td valign="bottom">1:500</td></tr><tr><td>Antibody</td><td valign="bottom">TorsinA</td><td valign="bottom">Abcam ab34540</td><td valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2240792">AB_2240792</ext-link></td><td valign="bottom">1:100</td></tr><tr><td>Antibody</td><td valign="bottom">anti-mouse</td><td valign="bottom">ThermoFisher <break/>A-31571</td><td valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_162542">AB_162542</ext-link></td><td valign="bottom">1:800</td></tr><tr><td>Antibody</td><td valign="bottom">anti-rabbit</td><td valign="bottom">ThermoFisher <break/>A-21206</td><td valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2535792">AB_2535792</ext-link></td><td valign="bottom">1:800</td></tr><tr><td>Antibody</td><td valign="bottom">anti-rabbit</td><td valign="bottom">ThermoFisher <break/>A-31572</td><td valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_162543">AB_162543</ext-link></td><td valign="bottom">1:800</td></tr><tr><td>Antibody</td><td valign="bottom">anti-goat</td><td valign="bottom">ThermoFisher <break/>A-21432</td><td valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2535853">AB_2535853</ext-link></td><td valign="bottom">1:800</td></tr><tr><td>Antibody</td><td valign="bottom">anti-goat</td><td valign="bottom">Jackson <break/>Immunoresearch <break/>705-065-003</td><td valign="bottom">RRID: <ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/AB_2340396">AB_2340396</ext-link></td><td valign="bottom">1:800</td></tr><tr><td>Commercial assay <break/>or kit</td><td>ABC HRP Kit <break/>(Standard)</td><td>Vector Laboratories</td><td>Pk-6100</td><td>Vectastain elite <break/>ABC kit</td></tr></tbody></table></table-wrap><sec id="s3-1"><title>Animals</title><p>ChAT-CKO mice were generated by crossing <italic>Chat<sup>tm2(cre)Lowl</sup></italic> mice (<xref ref-type="bibr" rid="bib59">Rossi et al., 2011</xref>) with <italic>Tor1a<sup>Flx/Flx</sup></italic> mice (<xref ref-type="bibr" rid="bib30">Liang et al., 2014</xref>), using the breeding strategy described in (<xref ref-type="bibr" rid="bib46">Pappas et al., 2015</xref>), and maintained as previously described (<xref ref-type="bibr" rid="bib46">Pappas et al., 2015</xref>).</p></sec><sec id="s3-2"><title>Sample size estimation</title><p>Sample sizes for histological and behavioral studies were determined by performing a power analysis of the open field or striatal cholinergic stereological data (mean and std. dev.) from (<xref ref-type="bibr" rid="bib46">Pappas et al., 2015</xref>), an alpha of 0.01, and beta of 0.1. (Kane SP. Sample Size Calculator. ClinCalc: <ext-link ext-link-type="uri" xlink:href="http://clincalc.com/stats/samplesize.aspx"><italic>http://clincalc.com/stats/samplesize.aspx</italic></ext-link>). Experimental cohorts were generated accordingly.</p></sec><sec id="s3-3"><title>Imaging and stereology</title><p>Brain sections were generated and stained with immunohistochemistry using the methods described in (<xref ref-type="bibr" rid="bib46">Pappas et al., 2015</xref>; <xref ref-type="bibr" rid="bib48">Pappas et al., 2018</xref>). Antibodies and reagents are listed in <xref ref-type="table" rid="table4">Table 4</xref>. Sections were observed with epifluorescence or brightfield microscopy (<xref ref-type="bibr" rid="bib48">Pappas et al., 2018</xref>), and unbiased stereological cell counting was performed with StereoInvestigator software using the Optical Fractionator probe (specific parameters in <xref ref-type="table" rid="table5">Table 5</xref>). Striatal cell density was quantified as done previously (<xref ref-type="bibr" rid="bib46">Pappas et al., 2015</xref>). Spinal cord neurons were quantified as described in (<xref ref-type="bibr" rid="bib25">Kim et al., 2017</xref>).</p><table-wrap id="table4" position="float"><object-id pub-id-type="doi">10.7554/eLife.36691.018</object-id><label>Table 4.</label><caption><title>Antibodies used for immunohistochemistry.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom">Level</th><th valign="bottom">Antigen</th><th valign="bottom">Host</th><th valign="bottom">Conjugated</th><th valign="bottom">Dilution</th><th valign="bottom">Source</th></tr></thead><tbody><tr><td valign="bottom">Primary</td><td valign="bottom">Choline Acetyltransferase</td><td valign="bottom">Goat</td><td valign="bottom">-</td><td valign="bottom">1:100</td><td valign="bottom">Millipore AB144P</td></tr><tr><td valign="bottom">Primary</td><td valign="bottom">P75 Neurotrophin Receptor</td><td valign="bottom">Goat</td><td valign="bottom">-</td><td valign="bottom">1:100</td><td valign="bottom">Santa Cruz sc6188</td></tr><tr><td valign="bottom">Primary</td><td valign="bottom">NeuN</td><td valign="bottom">Rabbit</td><td valign="bottom">-</td><td valign="bottom">1:500</td><td valign="bottom">Cell Signaling #12943</td></tr><tr><td valign="bottom">Primary</td><td valign="bottom">GFAP</td><td valign="bottom">Mouse</td><td valign="bottom">-</td><td valign="bottom">1:1000</td><td valign="bottom">Cell Signaling #3670P</td></tr><tr><td valign="bottom">Primary</td><td valign="bottom">Iba-1</td><td valign="bottom">Rabbit</td><td valign="bottom">-</td><td valign="bottom">1:500</td><td valign="bottom">Wako 019–19741</td></tr><tr><td valign="bottom">Primary</td><td valign="bottom">TorsinA</td><td valign="bottom">Rabbit</td><td valign="bottom">-</td><td valign="bottom">1:100</td><td valign="bottom">Abcam ab34540</td></tr><tr><td valign="bottom">Secondary</td><td valign="bottom">anti-mouse</td><td valign="bottom">Donkey</td><td valign="bottom">Alexafluor-647</td><td valign="bottom">1:800</td><td valign="bottom">ThermoFisher A-31571</td></tr><tr><td valign="bottom">Secondary</td><td valign="bottom">anti-rabbit</td><td valign="bottom">Donkey</td><td valign="bottom">Alexafluor-488</td><td valign="bottom">1:800</td><td valign="bottom">ThermoFisher A-21206</td></tr><tr><td valign="bottom">Secondary</td><td valign="bottom">anti-rabbit</td><td valign="bottom">Donkey</td><td valign="bottom">Alexafluor-555</td><td valign="bottom">1:800</td><td valign="bottom">ThermoFisher A-31572</td></tr><tr><td valign="bottom">Secondary</td><td valign="bottom">anti-goat</td><td valign="bottom">Donkey</td><td valign="bottom">Alexafluor-555</td><td valign="bottom">1:800</td><td valign="bottom">ThermoFisher A-21432</td></tr><tr><td valign="bottom">Secondary</td><td valign="bottom">anti-goat</td><td valign="bottom">Donkey</td><td valign="bottom">biotin</td><td valign="bottom">1:800</td><td valign="bottom">Jackson Immunoresearch 705-065-003</td></tr></tbody></table></table-wrap><table-wrap id="table5" position="float"><object-id pub-id-type="doi">10.7554/eLife.36691.019</object-id><label>Table 5.</label><caption><title>Stereology parameters.</title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="bottom">Region</th><th valign="bottom">Marker</th><th valign="bottom">Counting frame (μm)</th><th valign="bottom">Grid size (μm)</th><th valign="bottom">Guard zone (μm)</th><th valign="bottom">Dissector (μm)</th><th valign="bottom">Section cut thickness (μm)</th></tr></thead><tbody><tr><td valign="bottom">Striatum</td><td valign="bottom">ChAT</td><td valign="bottom">100 × 100</td><td valign="bottom">250 × 250</td><td valign="bottom">1</td><td valign="bottom">10</td><td valign="bottom">40</td></tr><tr><td valign="bottom">NBM</td><td valign="bottom">P75</td><td valign="bottom">90 × 90</td><td valign="bottom">200 × 200</td><td valign="bottom">5</td><td valign="bottom">30</td><td valign="bottom">50</td></tr><tr><td valign="bottom">MS/VDB</td><td valign="bottom">P75</td><td valign="bottom">90 × 90</td><td valign="bottom">200 × 200</td><td valign="bottom">5</td><td valign="bottom">30</td><td valign="bottom">50</td></tr><tr><td valign="bottom">GP</td><td valign="bottom">P75</td><td valign="bottom">100 × 100</td><td valign="bottom">140 × 140</td><td valign="bottom">5</td><td valign="bottom">30</td><td valign="bottom">50</td></tr><tr><td valign="bottom">PPN and LDT</td><td valign="bottom">ChAT</td><td valign="bottom">75 × 75</td><td valign="bottom">150 × 150</td><td valign="bottom">5</td><td valign="bottom">30</td><td valign="bottom">50</td></tr><tr><td valign="bottom">PPN and LDT</td><td valign="bottom">NeuN</td><td valign="bottom">40 × 40</td><td valign="bottom">250 × 250</td><td valign="bottom">5</td><td valign="bottom">30</td><td valign="bottom">50</td></tr></tbody></table></table-wrap></sec><sec id="s3-4"><title>Behavioral analysis</title><p>Tail suspension, forelimb wire suspension, open field, accelerating rotarod, and gait analysis were performed as described in (<xref ref-type="bibr" rid="bib46">Pappas et al., 2015</xref>). Kyphosis severity was scored as described in (<xref ref-type="bibr" rid="bib18">Guyenet et al., 2010</xref>).</p></sec><sec id="s3-5"><title>Statistical analysis</title><p>t-tests, one-way, or two-way ANOVA with posthoc corrections for multiple comparisons were performed to compare experimental groups (details in each figure legend). If variances were significantly different between groups, non-parametric tests were performed.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We thank Stephanie Mrowczynski for expert technical assistance and the Dauer lab for helpful comments and suggestions. This research was supported by generous support from Tyler’s Hope for a Dystonia Cure and the following grants: RO1NS077730 (William T Dauer), RO1NS057482, R21NS099921, and R56NS104218 (Umrao R Monani).</p></ack><sec id="s4" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Investigation, Writing—original draft, Writing—review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Investigation, Writing—review and editing</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation, Writing—review and editing</p></fn><fn fn-type="con" id="con4"><p>Investigation, Writing—review and editing</p></fn><fn fn-type="con" id="con5"><p>Resources, Supervision, Funding acquisition, Writing—review and editing</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Resources, Supervision, Funding acquisition, Writing—review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All experiments were performed according to the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All procedures involving animals were approved by the University of Michigan Institutional Animal Care and Use Committee (animal use protocol PRO00006600). All effort was taken to minimize the number of animals used and to prevent discomfort or distress.</p></fn></fn-group></sec><sec id="s5" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><object-id pub-id-type="doi">10.7554/eLife.36691.020</object-id><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-36691-transrepform-v2.docx"/></supplementary-material><sec id="s6" sec-type="data-availability"><title>Data availability</title><p>All data generated during this study are included in the manuscript and supporting files</p></sec></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albin</surname> <given-names>RL</given-names></name><name><surname>Cross</surname> <given-names>D</given-names></name><name><surname>Cornblath</surname> <given-names>WT</given-names></name><name><surname>Wald</surname> <given-names>JA</given-names></name><name><surname>Wernette</surname> <given-names>K</given-names></name><name><surname>Frey</surname> <given-names>KA</given-names></name><name><surname>Minoshima</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Diminished striatal [123I]iodobenzovesamicol binding in idiopathic cervical dystonia</article-title><source>Annals of Neurology</source><volume>53</volume><fpage>528</fpage><lpage>532</lpage><pub-id pub-id-type="doi">10.1002/ana.10527</pub-id><pub-id pub-id-type="pmid">12666122</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alexander</surname> <given-names>GE</given-names></name><name><surname>DeLong</surname> <given-names>MR</given-names></name><name><surname>Strick</surname> <given-names>PL</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>Parallel organization of functionally segregated circuits linking basal ganglia and cortex</article-title><source>Annual Review of Neuroscience</source><volume>9</volume><fpage>357</fpage><lpage>381</lpage><pub-id pub-id-type="doi">10.1146/annurev.ne.09.030186.002041</pub-id><pub-id pub-id-type="pmid">3085570</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aroca</surname> <given-names>P</given-names></name><name><surname>Puelles</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Postulated boundaries and differential fate in the developing rostral hindbrain</article-title><source>Brain Research Reviews</source><volume>49</volume><fpage>179</fpage><lpage>190</lpage><pub-id pub-id-type="doi">10.1016/j.brainresrev.2004.12.031</pub-id><pub-id pub-id-type="pmid">16111548</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ballinger</surname> <given-names>EC</given-names></name><name><surname>Ananth</surname> <given-names>M</given-names></name><name><surname>Talmage</surname> <given-names>DA</given-names></name><name><surname>Role</surname> <given-names>LW</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Basal Forebrain Cholinergic Circuits and Signaling in Cognition and Cognitive Decline</article-title><source>Neuron</source><volume>91</volume><fpage>1199</fpage><lpage>1218</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.09.006</pub-id><pub-id pub-id-type="pmid">27657448</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanco-Lezcano</surname> <given-names>L</given-names></name><name><surname>Jimenez-Martin</surname> <given-names>J</given-names></name><name><surname>Díaz-Hung</surname> <given-names>ML</given-names></name><name><surname>Alberti-Amador</surname> <given-names>E</given-names></name><name><surname>Wong-Guerra</surname> <given-names>M</given-names></name><name><surname>González-Fraguela</surname> <given-names>ME</given-names></name><name><surname>Estupiñán-Díaz</surname> <given-names>B</given-names></name><name><surname>Serrano-Sánchez</surname> <given-names>T</given-names></name><name><surname>Francis-Turner</surname> <given-names>L</given-names></name><name><surname>Delgado-Ocaña</surname> <given-names>S</given-names></name><name><surname>Núñez-Figueredo</surname> <given-names>Y</given-names></name><name><surname>Vega-Hurtado</surname> <given-names>Y</given-names></name><name><surname>Fernández-Jiménez</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Motor dysfunction and alterations in glutathione concentration, cholinesterase activity, and BDNF expression in substantia nigra pars compacta in rats with pedunculopontine lesion</article-title><source>Neuroscience</source><volume>348</volume><fpage>83</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2017.02.008</pub-id><pub-id pub-id-type="pmid">28212832</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bohnen</surname> <given-names>NI</given-names></name><name><surname>Müller</surname> <given-names>ML</given-names></name><name><surname>Koeppe</surname> <given-names>RA</given-names></name><name><surname>Studenski</surname> <given-names>SA</given-names></name><name><surname>Kilbourn</surname> <given-names>MA</given-names></name><name><surname>Frey</surname> <given-names>KA</given-names></name><name><surname>Albin</surname> <given-names>RL</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>History of falls in Parkinson disease is associated with reduced cholinergic activity</article-title><source>Neurology</source><volume>73</volume><fpage>1670</fpage><lpage>1676</lpage><pub-id pub-id-type="doi">10.1212/WNL.0b013e3181c1ded6</pub-id><pub-id pub-id-type="pmid">19917989</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bridges</surname> <given-names>LR</given-names></name><name><surname>Coulton</surname> <given-names>GR</given-names></name><name><surname>Howard</surname> <given-names>G</given-names></name><name><surname>Moss</surname> <given-names>J</given-names></name><name><surname>Mason</surname> <given-names>RM</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>The neuromuscular basis of hereditary kyphoscoliosis in the mouse</article-title><source>Muscle &amp; Nerve</source><volume>15</volume><fpage>172</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1002/mus.880150208</pub-id><pub-id pub-id-type="pmid">1372391</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burke</surname> <given-names>RE</given-names></name><name><surname>Fahn</surname> <given-names>S</given-names></name><name><surname>Marsden</surname> <given-names>CD</given-names></name></person-group><year iso-8601-date="1986">1986</year><article-title>Torsion dystonia: a double-blind, prospective trial of high-dosage trihexyphenidyl</article-title><source>Neurology</source><volume>36</volume><fpage>160</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.1212/WNL.36.2.160</pub-id><pub-id pub-id-type="pmid">3511401</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Capelli</surname> <given-names>P</given-names></name><name><surname>Pivetta</surname> <given-names>C</given-names></name><name><surname>Soledad Esposito</surname> <given-names>M</given-names></name><name><surname>Arber</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Locomotor speed control circuits in the caudal brainstem</article-title><source>Nature</source><volume>551</volume><fpage>373</fpage><lpage>377</lpage><pub-id pub-id-type="doi">10.1038/nature24064</pub-id><pub-id pub-id-type="pmid">29059682</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dautan</surname> <given-names>D</given-names></name><name><surname>Huerta-Ocampo</surname> <given-names>I</given-names></name><name><surname>Witten</surname> <given-names>IB</given-names></name><name><surname>Deisseroth</surname> <given-names>K</given-names></name><name><surname>Bolam</surname> <given-names>JP</given-names></name><name><surname>Gerdjikov</surname> <given-names>T</given-names></name><name><surname>Mena-Segovia</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A major external source of cholinergic innervation of the striatum and nucleus accumbens originates in the brainstem</article-title><source>Journal of Neuroscience</source><volume>34</volume><fpage>4509</fpage><lpage>4518</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5071-13.2014</pub-id><pub-id pub-id-type="pmid">24671996</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deconinck</surname> <given-names>AE</given-names></name><name><surname>Rafael</surname> <given-names>JA</given-names></name><name><surname>Skinner</surname> <given-names>JA</given-names></name><name><surname>Brown</surname> <given-names>SC</given-names></name><name><surname>Potter</surname> <given-names>AC</given-names></name><name><surname>Metzinger</surname> <given-names>L</given-names></name><name><surname>Watt</surname> <given-names>DJ</given-names></name><name><surname>Dickson</surname> <given-names>JG</given-names></name><name><surname>Tinsley</surname> <given-names>JM</given-names></name><name><surname>Davies</surname> <given-names>KE</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy</article-title><source>Cell</source><volume>90</volume><fpage>717</fpage><lpage>727</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)80532-2</pub-id><pub-id pub-id-type="pmid">9288751</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dickinson</surname> <given-names>AG</given-names></name><name><surname>Meikle</surname> <given-names>VM</given-names></name></person-group><year iso-8601-date="1973">1973</year><article-title>Genetic kyphoscoliosis in mice</article-title><source>The Lancet</source><volume>1</volume><fpage>1186</fpage><pub-id pub-id-type="doi">10.1016/S0140-6736(73)91186-0</pub-id><pub-id pub-id-type="pmid">4123573</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eskow Jaunarajs</surname> <given-names>KL</given-names></name><name><surname>Bonsi</surname> <given-names>P</given-names></name><name><surname>Chesselet</surname> <given-names>MF</given-names></name><name><surname>Standaert</surname> <given-names>DG</given-names></name><name><surname>Pisani</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Striatal cholinergic dysfunction as a unifying theme in the pathophysiology of dystonia</article-title><source>Progress in Neurobiology</source><volume>127-128</volume><fpage>91</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1016/j.pneurobio.2015.02.002</pub-id><pub-id pub-id-type="pmid">25697043</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Rill</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>The pedunculopontine nucleus</article-title><source>Progress in Neurobiology</source><volume>36</volume><fpage>363</fpage><lpage>389</lpage><pub-id pub-id-type="doi">10.1016/0301-0082(91)90016-T</pub-id><pub-id pub-id-type="pmid">1887068</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzales</surname> <given-names>KK</given-names></name><name><surname>Smith</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions</article-title><source>Annals of the New York Academy of Sciences</source><volume>1349</volume><fpage>1</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1111/nyas.12762</pub-id><pub-id pub-id-type="pmid">25876458</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grabli</surname> <given-names>D</given-names></name><name><surname>Karachi</surname> <given-names>C</given-names></name><name><surname>Folgoas</surname> <given-names>E</given-names></name><name><surname>Monfort</surname> <given-names>M</given-names></name><name><surname>Tande</surname> <given-names>D</given-names></name><name><surname>Clark</surname> <given-names>S</given-names></name><name><surname>Civelli</surname> <given-names>O</given-names></name><name><surname>Hirsch</surname> <given-names>EC</given-names></name><name><surname>François</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Gait disorders in parkinsonian monkeys with pedunculopontine nucleus lesions: a tale of two systems</article-title><source>Journal of Neuroscience</source><volume>33</volume><fpage>11986</fpage><lpage>11993</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1568-13.2013</pub-id><pub-id pub-id-type="pmid">23864685</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grady</surname> <given-names>RM</given-names></name><name><surname>Teng</surname> <given-names>H</given-names></name><name><surname>Nichol</surname> <given-names>MC</given-names></name><name><surname>Cunningham</surname> <given-names>JC</given-names></name><name><surname>Wilkinson</surname> <given-names>RS</given-names></name><name><surname>Sanes</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy</article-title><source>Cell</source><volume>90</volume><fpage>729</fpage><lpage>738</lpage><pub-id pub-id-type="doi">10.1016/S0092-8674(00)80533-4</pub-id><pub-id pub-id-type="pmid">9288752</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guyenet</surname> <given-names>SJ</given-names></name><name><surname>Furrer</surname> <given-names>SA</given-names></name><name><surname>Damian</surname> <given-names>VM</given-names></name><name><surname>Baughan</surname> <given-names>TD</given-names></name><name><surname>La Spada</surname> <given-names>AR</given-names></name><name><surname>Garden</surname> <given-names>GA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia</article-title><source>Journal of Visualized Experiments</source><pub-id pub-id-type="doi">10.3791/1787</pub-id><pub-id pub-id-type="pmid">20495529</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haber</surname> <given-names>SN</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Corticostriatal circuitry</article-title><source>Dialogues in Clinical Neuroscience</source><volume>18</volume><fpage>7</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">27069376</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hasselmo</surname> <given-names>ME</given-names></name><name><surname>Sarter</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Modes and models of forebrain cholinergic neuromodulation of cognition</article-title><source>Neuropsychopharmacology</source><volume>36</volume><fpage>52</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1038/npp.2010.104</pub-id><pub-id pub-id-type="pmid">20668433</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jankovic</surname> <given-names>J</given-names></name><name><surname>Patel</surname> <given-names>SC</given-names></name></person-group><year iso-8601-date="1983">1983</year><article-title>Blepharospasm associated with brainstem lesions</article-title><source>Neurology</source><volume>33</volume><fpage>1237</fpage><lpage>1240</lpage><pub-id pub-id-type="doi">10.1212/WNL.33.9.1237</pub-id><pub-id pub-id-type="pmid">6684264</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaneko</surname> <given-names>S</given-names></name><name><surname>Hikida</surname> <given-names>T</given-names></name><name><surname>Watanabe</surname> <given-names>D</given-names></name><name><surname>Ichinose</surname> <given-names>H</given-names></name><name><surname>Nagatsu</surname> <given-names>T</given-names></name><name><surname>Kreitman</surname> <given-names>RJ</given-names></name><name><surname>Pastan</surname> <given-names>I</given-names></name><name><surname>Nakanishi</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Synaptic integration mediated by striatal cholinergic interneurons in basal ganglia function</article-title><source>Science</source><volume>289</volume><fpage>633</fpage><lpage>637</lpage><pub-id pub-id-type="doi">10.1126/science.289.5479.633</pub-id><pub-id pub-id-type="pmid">10915629</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanning</surname> <given-names>KC</given-names></name><name><surname>Kaplan</surname> <given-names>A</given-names></name><name><surname>Henderson</surname> <given-names>CE</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Motor neuron diversity in development and disease</article-title><source>Annual Review of Neuroscience</source><volume>33</volume><fpage>409</fpage><lpage>440</lpage><pub-id pub-id-type="doi">10.1146/annurev.neuro.051508.135722</pub-id><pub-id pub-id-type="pmid">20367447</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karachi</surname> <given-names>C</given-names></name><name><surname>Grabli</surname> <given-names>D</given-names></name><name><surname>Bernard</surname> <given-names>FA</given-names></name><name><surname>Tandé</surname> <given-names>D</given-names></name><name><surname>Wattiez</surname> <given-names>N</given-names></name><name><surname>Belaid</surname> <given-names>H</given-names></name><name><surname>Bardinet</surname> <given-names>E</given-names></name><name><surname>Prigent</surname> <given-names>A</given-names></name><name><surname>Nothacker</surname> <given-names>HP</given-names></name><name><surname>Hunot</surname> <given-names>S</given-names></name><name><surname>Hartmann</surname> <given-names>A</given-names></name><name><surname>Lehéricy</surname> <given-names>S</given-names></name><name><surname>Hirsch</surname> <given-names>EC</given-names></name><name><surname>François</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Cholinergic mesencephalic neurons are involved in gait and postural disorders in Parkinson disease</article-title><source>Journal of Clinical Investigation</source><volume>120</volume><fpage>2745</fpage><lpage>2754</lpage><pub-id pub-id-type="doi">10.1172/JCI42642</pub-id><pub-id pub-id-type="pmid">20628197</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>JK</given-names></name><name><surname>Caine</surname> <given-names>C</given-names></name><name><surname>Awano</surname> <given-names>T</given-names></name><name><surname>Herbst</surname> <given-names>R</given-names></name><name><surname>Monani</surname> <given-names>UR</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Motor neuronal repletion of the NMJ organizer, Agrin, modulates the severity of the spinal muscular atrophy disease phenotype in model mice</article-title><source>Human Molecular Genetics</source><volume>26</volume><fpage>2377</fpage><lpage>2385</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddx124</pub-id><pub-id pub-id-type="pmid">28379354</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname> <given-names>C</given-names></name><name><surname>Fahn</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Translation of Oppenheim's 1911 paper on dystonia</article-title><source>Movement Disorders</source><volume>28</volume><fpage>851</fpage><lpage>862</lpage><pub-id pub-id-type="doi">10.1002/mds.25546</pub-id><pub-id pub-id-type="pmid">23893442</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreitzer</surname> <given-names>AC</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Physiology and pharmacology of striatal neurons</article-title><source>Annual Review of Neuroscience</source><volume>32</volume><fpage>127</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1146/annurev.neuro.051508.135422</pub-id><pub-id pub-id-type="pmid">19400717</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laws</surname> <given-names>N</given-names></name><name><surname>Hoey</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Progression of kyphosis in mdx mice</article-title><source>Journal of Applied Physiology</source><volume>97</volume><fpage>1970</fpage><lpage>1977</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.01357.2003</pub-id><pub-id pub-id-type="pmid">15234960</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LeDoux</surname> <given-names>MS</given-names></name><name><surname>Brady</surname> <given-names>KA</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Secondary cervical dystonia associated with structural lesions of the central nervous system</article-title><source>Movement Disorders</source><volume>18</volume><fpage>60</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1002/mds.10301</pub-id><pub-id pub-id-type="pmid">12518301</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname> <given-names>CC</given-names></name><name><surname>Tanabe</surname> <given-names>LM</given-names></name><name><surname>Jou</surname> <given-names>S</given-names></name><name><surname>Chi</surname> <given-names>F</given-names></name><name><surname>Dauer</surname> <given-names>WT</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>TorsinA hypofunction causes abnormal twisting movements and sensorimotor circuit neurodegeneration</article-title><source>Journal of Clinical Investigation</source><volume>124</volume><fpage>3080</fpage><lpage>3092</lpage><pub-id pub-id-type="doi">10.1172/JCI72830</pub-id><pub-id pub-id-type="pmid">24937429</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Pattamatta</surname> <given-names>A</given-names></name><name><surname>Zu</surname> <given-names>T</given-names></name><name><surname>Reid</surname> <given-names>T</given-names></name><name><surname>Bardhi</surname> <given-names>O</given-names></name><name><surname>Borchelt</surname> <given-names>DR</given-names></name><name><surname>Yachnis</surname> <given-names>AT</given-names></name><name><surname>Ranum</surname> <given-names>LP</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>C9orf72 BAC Mouse Model with Motor Deficits and Neurodegenerative Features of ALS/FTD</article-title><source>Neuron</source><volume>90</volume><fpage>521</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.04.005</pub-id><pub-id pub-id-type="pmid">27112499</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loher</surname> <given-names>TJ</given-names></name><name><surname>Krauss</surname> <given-names>JK</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Dystonia associated with pontomesencephalic lesions</article-title><source>Movement Disorders</source><volume>24</volume><fpage>157</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1002/mds.22196</pub-id><pub-id pub-id-type="pmid">18951533</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacLaren</surname> <given-names>DA</given-names></name><name><surname>Markovic</surname> <given-names>T</given-names></name><name><surname>Clark</surname> <given-names>SD</given-names></name></person-group><year iso-8601-date="2014">2014a</year><article-title>Assessment of sensorimotor gating following selective lesions of cholinergic pedunculopontine neurons</article-title><source>European Journal of Neuroscience</source><volume>40</volume><fpage>3526</fpage><lpage>3537</lpage><pub-id pub-id-type="doi">10.1111/ejn.12716</pub-id><pub-id pub-id-type="pmid">25208852</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacLaren</surname> <given-names>DA</given-names></name><name><surname>Santini</surname> <given-names>JA</given-names></name><name><surname>Russell</surname> <given-names>AL</given-names></name><name><surname>Markovic</surname> <given-names>T</given-names></name><name><surname>Clark</surname> <given-names>SD</given-names></name></person-group><year iso-8601-date="2014">2014b</year><article-title>Deficits in motor performance after pedunculopontine lesions in rats--impairment depends on demands of task</article-title><source>European Journal of Neuroscience</source><volume>40</volume><fpage>3224</fpage><lpage>3236</lpage><pub-id pub-id-type="doi">10.1111/ejn.12666</pub-id><pub-id pub-id-type="pmid">24995993</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Madisen</surname> <given-names>L</given-names></name><name><surname>Zwingman</surname> <given-names>TA</given-names></name><name><surname>Sunkin</surname> <given-names>SM</given-names></name><name><surname>Oh</surname> <given-names>SW</given-names></name><name><surname>Zariwala</surname> <given-names>HA</given-names></name><name><surname>Gu</surname> <given-names>H</given-names></name><name><surname>Ng</surname> <given-names>LL</given-names></name><name><surname>Palmiter</surname> <given-names>RD</given-names></name><name><surname>Hawrylycz</surname> <given-names>MJ</given-names></name><name><surname>Jones</surname> <given-names>AR</given-names></name><name><surname>Lein</surname> <given-names>ES</given-names></name><name><surname>Zeng</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>A robust and high-throughput Cre reporting and characterization system for the whole mouse brain</article-title><source>Nature Neuroscience</source><volume>13</volume><fpage>133</fpage><lpage>140</lpage><pub-id pub-id-type="doi">10.1038/nn.2467</pub-id><pub-id pub-id-type="pmid">20023653</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maltese</surname> <given-names>M</given-names></name><name><surname>Martella</surname> <given-names>G</given-names></name><name><surname>Madeo</surname> <given-names>G</given-names></name><name><surname>Fagiolo</surname> <given-names>I</given-names></name><name><surname>Tassone</surname> <given-names>A</given-names></name><name><surname>Ponterio</surname> <given-names>G</given-names></name><name><surname>Sciamanna</surname> <given-names>G</given-names></name><name><surname>Burbaud</surname> <given-names>P</given-names></name><name><surname>Conn</surname> <given-names>PJ</given-names></name><name><surname>Bonsi</surname> <given-names>P</given-names></name><name><surname>Pisani</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Anticholinergic drugs rescue synaptic plasticity in DYT1 dystonia: role of M1 muscarinic receptors</article-title><source>Movement Disorders</source><volume>29</volume><fpage>1655</fpage><lpage>1665</lpage><pub-id pub-id-type="doi">10.1002/mds.26009</pub-id><pub-id pub-id-type="pmid">25195914</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manns</surname> <given-names>ID</given-names></name><name><surname>Alonso</surname> <given-names>A</given-names></name><name><surname>Jones</surname> <given-names>BE</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Discharge properties of juxtacellularly labeled and immunohistochemically identified cholinergic basal forebrain neurons recorded in association with the electroencephalogram in anesthetized rats</article-title><source>The Journal of Neuroscience</source><volume>20</volume><fpage>1505</fpage><lpage>1518</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.20-04-01505.2000</pub-id><pub-id pub-id-type="pmid">10662840</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martella</surname> <given-names>G</given-names></name><name><surname>Tassone</surname> <given-names>A</given-names></name><name><surname>Sciamanna</surname> <given-names>G</given-names></name><name><surname>Platania</surname> <given-names>P</given-names></name><name><surname>Cuomo</surname> <given-names>D</given-names></name><name><surname>Viscomi</surname> <given-names>MT</given-names></name><name><surname>Bonsi</surname> <given-names>P</given-names></name><name><surname>Cacci</surname> <given-names>E</given-names></name><name><surname>Biagioni</surname> <given-names>S</given-names></name><name><surname>Usiello</surname> <given-names>A</given-names></name><name><surname>Bernardi</surname> <given-names>G</given-names></name><name><surname>Sharma</surname> <given-names>N</given-names></name><name><surname>Standaert</surname> <given-names>DG</given-names></name><name><surname>Pisani</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Impairment of bidirectional synaptic plasticity in the striatum of a mouse model of DYT1 dystonia: role of endogenous acetylcholine</article-title><source>Brain</source><volume>132</volume><fpage>2336</fpage><lpage>2349</lpage><pub-id pub-id-type="doi">10.1093/brain/awp194</pub-id><pub-id pub-id-type="pmid">19641103</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNaught</surname> <given-names>KS</given-names></name><name><surname>Kapustin</surname> <given-names>A</given-names></name><name><surname>Jackson</surname> <given-names>T</given-names></name><name><surname>Jengelley</surname> <given-names>TA</given-names></name><name><surname>Jnobaptiste</surname> <given-names>R</given-names></name><name><surname>Shashidharan</surname> <given-names>P</given-names></name><name><surname>Perl</surname> <given-names>DP</given-names></name><name><surname>Pasik</surname> <given-names>P</given-names></name><name><surname>Olanow</surname> <given-names>CW</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Brainstem pathology in DYT1 primary torsion dystonia</article-title><source>Annals of Neurology</source><volume>56</volume><fpage>540</fpage><lpage>547</lpage><pub-id pub-id-type="doi">10.1002/ana.20225</pub-id><pub-id pub-id-type="pmid">15455404</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mena-Segovia</surname> <given-names>J</given-names></name><name><surname>Bolam</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Rethinking the Pedunculopontine Nucleus: From Cellular Organization to Function</article-title><source>Neuron</source><volume>94</volume><fpage>7</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2017.02.027</pub-id><pub-id pub-id-type="pmid">28384477</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mena-Segovia</surname> <given-names>J</given-names></name><name><surname>Micklem</surname> <given-names>BR</given-names></name><name><surname>Nair-Roberts</surname> <given-names>RG</given-names></name><name><surname>Ungless</surname> <given-names>MA</given-names></name><name><surname>Bolam</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>GABAergic neuron distribution in the pedunculopontine nucleus defines functional subterritories</article-title><source>The Journal of Comparative Neurology</source><volume>515</volume><fpage>397</fpage><lpage>408</lpage><pub-id pub-id-type="doi">10.1002/cne.22065</pub-id><pub-id pub-id-type="pmid">19459217</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mena-Segovia</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Structural and functional considerations of the cholinergic brainstem</article-title><source>Journal of Neural Transmission</source><volume>123</volume><fpage>731</fpage><lpage>736</lpage><pub-id pub-id-type="doi">10.1007/s00702-016-1530-9</pub-id><pub-id pub-id-type="pmid">26945862</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mente</surname> <given-names>K</given-names></name><name><surname>Edwards</surname> <given-names>NA</given-names></name><name><surname>Urbano</surname> <given-names>D</given-names></name><name><surname>Ray-Chaudhury</surname> <given-names>A</given-names></name><name><surname>Iacono</surname> <given-names>D</given-names></name><name><surname>Alho</surname> <given-names>A</given-names></name><name><surname>Alho</surname> <given-names>EJL</given-names></name><name><surname>Amaro</surname> <given-names>E</given-names></name><name><surname>Horovitz</surname> <given-names>SG</given-names></name><name><surname>Hallett</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Pedunculopontine Nucleus Cholinergic Deficiency in Cervical Dystonia</article-title><source>Movement Disorders</source><volume>33</volume><fpage>827</fpage><lpage>834</lpage><pub-id pub-id-type="doi">10.1002/mds.27358</pub-id><pub-id pub-id-type="pmid">29508906</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monks</surname> <given-names>DA</given-names></name><name><surname>Johansen</surname> <given-names>JA</given-names></name><name><surname>Mo</surname> <given-names>K</given-names></name><name><surname>Rao</surname> <given-names>P</given-names></name><name><surname>Eagleson</surname> <given-names>B</given-names></name><name><surname>Yu</surname> <given-names>Z</given-names></name><name><surname>Lieberman</surname> <given-names>AP</given-names></name><name><surname>Breedlove</surname> <given-names>SM</given-names></name><name><surname>Jordan</surname> <given-names>CL</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease</article-title><source>PNAS</source><volume>104</volume><fpage>18259</fpage><lpage>18264</lpage><pub-id pub-id-type="doi">10.1073/pnas.0705501104</pub-id><pub-id pub-id-type="pmid">17984063</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozelius</surname> <given-names>LJ</given-names></name><name><surname>Hewett</surname> <given-names>JW</given-names></name><name><surname>Page</surname> <given-names>CE</given-names></name><name><surname>Bressman</surname> <given-names>SB</given-names></name><name><surname>Kramer</surname> <given-names>PL</given-names></name><name><surname>Shalish</surname> <given-names>C</given-names></name><name><surname>de Leon</surname> <given-names>D</given-names></name><name><surname>Brin</surname> <given-names>MF</given-names></name><name><surname>Raymond</surname> <given-names>D</given-names></name><name><surname>Corey</surname> <given-names>DP</given-names></name><name><surname>Fahn</surname> <given-names>S</given-names></name><name><surname>Risch</surname> <given-names>NJ</given-names></name><name><surname>Buckler</surname> <given-names>AJ</given-names></name><name><surname>Gusella</surname> <given-names>JF</given-names></name><name><surname>Breakefield</surname> <given-names>XO</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein</article-title><source>Nature Genetics</source><volume>17</volume><fpage>40</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1038/ng0997-40</pub-id><pub-id pub-id-type="pmid">9288096</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pappas</surname> <given-names>SS</given-names></name><name><surname>Darr</surname> <given-names>K</given-names></name><name><surname>Holley</surname> <given-names>SM</given-names></name><name><surname>Cepeda</surname> <given-names>C</given-names></name><name><surname>Mabrouk</surname> <given-names>OS</given-names></name><name><surname>Wong</surname> <given-names>JM</given-names></name><name><surname>LeWitt</surname> <given-names>TM</given-names></name><name><surname>Paudel</surname> <given-names>R</given-names></name><name><surname>Houlden</surname> <given-names>H</given-names></name><name><surname>Kennedy</surname> <given-names>RT</given-names></name><name><surname>Levine</surname> <given-names>MS</given-names></name><name><surname>Dauer</surname> <given-names>WT</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Forebrain deletion of the dystonia protein torsinA causes dystonic-like movements and loss of striatal cholinergic neurons</article-title><source>eLife</source><volume>4</volume><elocation-id>e08352</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.08352</pub-id><pub-id pub-id-type="pmid">26052670</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pappas</surname> <given-names>SS</given-names></name><name><surname>Leventhal</surname> <given-names>DK</given-names></name><name><surname>Albin</surname> <given-names>RL</given-names></name><name><surname>Dauer</surname> <given-names>WT</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Mouse models of neurodevelopmental disease of the basal ganglia and associated circuits</article-title><source>Current Topics in Developmental Biology</source><volume>109</volume><fpage>97</fpage><lpage>169</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-397920-9.00001-9</pub-id><pub-id pub-id-type="pmid">24947237</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pappas</surname> <given-names>SS</given-names></name><name><surname>Liang</surname> <given-names>CC</given-names></name><name><surname>Kim</surname> <given-names>S</given-names></name><name><surname>Rivera</surname> <given-names>CO</given-names></name><name><surname>Dauer</surname> <given-names>WT</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>TorsinA dysfunction causes persistent neuronal nuclear pore defects</article-title><source>Human Molecular Genetics</source><volume>27</volume><fpage>407</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddx405</pub-id><pub-id pub-id-type="pmid">29186574</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parent</surname> <given-names>A</given-names></name><name><surname>Hazrati</surname> <given-names>LN</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop</article-title><source>Brain Research Reviews</source><volume>20</volume><fpage>91</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1016/0165-0173(94)00007-C</pub-id><pub-id pub-id-type="pmid">7711769</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paudel</surname> <given-names>R</given-names></name><name><surname>Kiely</surname> <given-names>A</given-names></name><name><surname>Li</surname> <given-names>A</given-names></name><name><surname>Lashley</surname> <given-names>T</given-names></name><name><surname>Bandopadhyay</surname> <given-names>R</given-names></name><name><surname>Hardy</surname> <given-names>J</given-names></name><name><surname>Jinnah</surname> <given-names>HA</given-names></name><name><surname>Bhatia</surname> <given-names>K</given-names></name><name><surname>Houlden</surname> <given-names>H</given-names></name><name><surname>Holton</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Neuropathological features of genetically confirmed DYT1 dystonia: investigating disease-specific inclusions</article-title><source>Acta Neuropathologica Communications</source><volume>2</volume><fpage>159</fpage><pub-id pub-id-type="doi">10.1186/s40478-014-0159-x</pub-id><pub-id pub-id-type="pmid">25403864</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petzold</surname> <given-names>A</given-names></name><name><surname>Valencia</surname> <given-names>M</given-names></name><name><surname>Pál</surname> <given-names>B</given-names></name><name><surname>Mena-Segovia</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Decoding brain state transitions in the pedunculopontine nucleus: cooperative phasic and tonic mechanisms</article-title><source>Frontiers in Neural Circuits</source><volume>9</volume><elocation-id>68</elocation-id><pub-id pub-id-type="doi">10.3389/fncir.2015.00068</pub-id><pub-id pub-id-type="pmid">26582977</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phelps</surname> <given-names>PE</given-names></name><name><surname>Barber</surname> <given-names>RP</given-names></name><name><surname>Brennan</surname> <given-names>LA</given-names></name><name><surname>Maines</surname> <given-names>VM</given-names></name><name><surname>Salvaterra</surname> <given-names>PM</given-names></name><name><surname>Vaughn</surname> <given-names>JE</given-names></name></person-group><year iso-8601-date="1990">1990a</year><article-title>Embryonic development of four different subsets of cholinergic neurons in rat cervical spinal cord</article-title><source>The Journal of Comparative Neurology</source><volume>291</volume><fpage>9</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1002/cne.902910103</pub-id><pub-id pub-id-type="pmid">2298930</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phelps</surname> <given-names>PE</given-names></name><name><surname>Barber</surname> <given-names>RP</given-names></name><name><surname>Vaughn</surname> <given-names>JE</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Generation patterns of four groups of cholinergic neurons in rat cervical spinal cord: a combined tritiated thymidine autoradiographic and choline acetyltransferase immunocytochemical study</article-title><source>The Journal of Comparative Neurology</source><volume>273</volume><fpage>459</fpage><lpage>472</lpage><pub-id pub-id-type="doi">10.1002/cne.902730403</pub-id><pub-id pub-id-type="pmid">3209733</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phelps</surname> <given-names>PE</given-names></name><name><surname>Brady</surname> <given-names>DR</given-names></name><name><surname>Vaughn</surname> <given-names>JE</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>The generation and differentiation of cholinergic neurons in rat caudate-putamen</article-title><source>Developmental Brain Research</source><volume>46</volume><fpage>47</fpage><lpage>60</lpage><pub-id pub-id-type="doi">10.1016/0165-3806(89)90142-9</pub-id><pub-id pub-id-type="pmid">2706771</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Phelps</surname> <given-names>PE</given-names></name><name><surname>Brennan</surname> <given-names>LA</given-names></name><name><surname>Vaughn</surname> <given-names>JE</given-names></name></person-group><year iso-8601-date="1990">1990b</year><article-title>Generation patterns of immunocytochemically identified cholinergic neurons in rat brainstem</article-title><source>Developmental Brain Research</source><volume>56</volume><fpage>63</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/0165-3806(90)90165-U</pub-id><pub-id pub-id-type="pmid">2279332</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pisani</surname> <given-names>A</given-names></name><name><surname>Martella</surname> <given-names>G</given-names></name><name><surname>Tscherter</surname> <given-names>A</given-names></name><name><surname>Bonsi</surname> <given-names>P</given-names></name><name><surname>Sharma</surname> <given-names>N</given-names></name><name><surname>Bernardi</surname> <given-names>G</given-names></name><name><surname>Standaert</surname> <given-names>DG</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Altered responses to dopaminergic D2 receptor activation and N-type calcium currents in striatal cholinergic interneurons in a mouse model of DYT1 dystonia</article-title><source>Neurobiology of Disease</source><volume>24</volume><fpage>318</fpage><lpage>325</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2006.07.006</pub-id><pub-id pub-id-type="pmid">16934985</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pratt</surname> <given-names>D</given-names></name><name><surname>Mente</surname> <given-names>K</given-names></name><name><surname>Rahimpour</surname> <given-names>S</given-names></name><name><surname>Edwards</surname> <given-names>NA</given-names></name><name><surname>Tinaz</surname> <given-names>S</given-names></name><name><surname>Berman</surname> <given-names>BD</given-names></name><name><surname>Hallett</surname> <given-names>M</given-names></name><name><surname>Ray-Chaudhury</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Diminishing evidence for torsinA-positive neuronal inclusions in DYT1 dystonia</article-title><source>Acta Neuropathologica Communications</source><volume>4</volume><fpage>85</fpage><pub-id pub-id-type="doi">10.1186/s40478-016-0362-z</pub-id><pub-id pub-id-type="pmid">27531128</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roseberry</surname> <given-names>TK</given-names></name><name><surname>Lee</surname> <given-names>AM</given-names></name><name><surname>Lalive</surname> <given-names>AL</given-names></name><name><surname>Wilbrecht</surname> <given-names>L</given-names></name><name><surname>Bonci</surname> <given-names>A</given-names></name><name><surname>Kreitzer</surname> <given-names>AC</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cell-Type-Specific Control of Brainstem Locomotor Circuits by Basal Ganglia</article-title><source>Cell</source><volume>164</volume><fpage>526</fpage><lpage>537</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.12.037</pub-id><pub-id pub-id-type="pmid">26824660</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossi</surname> <given-names>J</given-names></name><name><surname>Balthasar</surname> <given-names>N</given-names></name><name><surname>Olson</surname> <given-names>D</given-names></name><name><surname>Scott</surname> <given-names>M</given-names></name><name><surname>Berglund</surname> <given-names>E</given-names></name><name><surname>Lee</surname> <given-names>CE</given-names></name><name><surname>Choi</surname> <given-names>MJ</given-names></name><name><surname>Lauzon</surname> <given-names>D</given-names></name><name><surname>Lowell</surname> <given-names>BB</given-names></name><name><surname>Elmquist</surname> <given-names>JK</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Melanocortin-4 receptors expressed by cholinergic neurons regulate energy balance and glucose homeostasis</article-title><source>Cell Metabolism</source><volume>13</volume><fpage>195</fpage><lpage>204</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2011.01.010</pub-id><pub-id pub-id-type="pmid">21284986</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schambra</surname> <given-names>UB</given-names></name><name><surname>Sulik</surname> <given-names>KK</given-names></name><name><surname>Petrusz</surname> <given-names>P</given-names></name><name><surname>Lauder</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="1989">1989</year><article-title>Ontogeny of cholinergic neurons in the mouse forebrain</article-title><source>The Journal of Comparative Neurology</source><volume>288</volume><fpage>101</fpage><lpage>122</lpage><pub-id pub-id-type="doi">10.1002/cne.902880109</pub-id><pub-id pub-id-type="pmid">2794134</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sciamanna</surname> <given-names>G</given-names></name><name><surname>Hollis</surname> <given-names>R</given-names></name><name><surname>Ball</surname> <given-names>C</given-names></name><name><surname>Martella</surname> <given-names>G</given-names></name><name><surname>Tassone</surname> <given-names>A</given-names></name><name><surname>Marshall</surname> <given-names>A</given-names></name><name><surname>Parsons</surname> <given-names>D</given-names></name><name><surname>Li</surname> <given-names>X</given-names></name><name><surname>Yokoi</surname> <given-names>F</given-names></name><name><surname>Zhang</surname> <given-names>L</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Pisani</surname> <given-names>A</given-names></name><name><surname>Standaert</surname> <given-names>DG</given-names></name></person-group><year iso-8601-date="2012">2012b</year><article-title>Cholinergic dysregulation produced by selective inactivation of the dystonia-associated protein torsinA</article-title><source>Neurobiology of Disease</source><volume>47</volume><fpage>416</fpage><lpage>427</lpage><pub-id pub-id-type="doi">10.1016/j.nbd.2012.04.015</pub-id><pub-id pub-id-type="pmid">22579992</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sciamanna</surname> <given-names>G</given-names></name><name><surname>Tassone</surname> <given-names>A</given-names></name><name><surname>Mandolesi</surname> <given-names>G</given-names></name><name><surname>Puglisi</surname> <given-names>F</given-names></name><name><surname>Ponterio</surname> <given-names>G</given-names></name><name><surname>Martella</surname> <given-names>G</given-names></name><name><surname>Madeo</surname> <given-names>G</given-names></name><name><surname>Bernardi</surname> <given-names>G</given-names></name><name><surname>Standaert</surname> <given-names>DG</given-names></name><name><surname>Bonsi</surname> <given-names>P</given-names></name><name><surname>Pisani</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2012">2012a</year><article-title>Cholinergic dysfunction alters synaptic integration between thalamostriatal and corticostriatal inputs in DYT1 dystonia</article-title><source>Journal of Neuroscience</source><volume>32</volume><fpage>11991</fpage><lpage>12004</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0041-12.2012</pub-id><pub-id pub-id-type="pmid">22933784</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semba</surname> <given-names>K</given-names></name><name><surname>Fibiger</surname> <given-names>HC</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Afferent connections of the laterodorsal and the pedunculopontine tegmental nuclei in the rat: a retro- and antero-grade transport and immunohistochemical study</article-title><source>The Journal of Comparative Neurology</source><volume>323</volume><fpage>387</fpage><lpage>410</lpage><pub-id pub-id-type="doi">10.1002/cne.903230307</pub-id><pub-id pub-id-type="pmid">1281170</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semba</surname> <given-names>K</given-names></name><name><surname>Vincent</surname> <given-names>SR</given-names></name><name><surname>Fibiger</surname> <given-names>HC</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Different times of origin of choline acetyltransferase- and somatostatin-immunoreactive neurons in the rat striatum</article-title><source>The Journal of Neuroscience</source><volume>8</volume><fpage>3937</fpage><lpage>3944</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.08-10-03937.1988</pub-id><pub-id pub-id-type="pmid">2903916</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname> <given-names>Y</given-names></name><name><surname>Raju</surname> <given-names>DV</given-names></name><name><surname>Pare</surname> <given-names>JF</given-names></name><name><surname>Sidibe</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>The thalamostriatal system: a highly specific network of the basal ganglia circuitry</article-title><source>Trends in Neurosciences</source><volume>27</volume><fpage>520</fpage><lpage>527</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2004.07.004</pub-id><pub-id pub-id-type="pmid">15331233</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sopher</surname> <given-names>BL</given-names></name><name><surname>Thomas</surname> <given-names>PS</given-names></name><name><surname>LaFevre-Bernt</surname> <given-names>MA</given-names></name><name><surname>Holm</surname> <given-names>IE</given-names></name><name><surname>Wilke</surname> <given-names>SA</given-names></name><name><surname>Ware</surname> <given-names>CB</given-names></name><name><surname>Jin</surname> <given-names>LW</given-names></name><name><surname>Libby</surname> <given-names>RT</given-names></name><name><surname>Ellerby</surname> <given-names>LM</given-names></name><name><surname>La Spada</surname> <given-names>AR</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Androgen receptor YAC transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration</article-title><source>Neuron</source><volume>41</volume><fpage>687</fpage><lpage>699</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(04)00082-0</pub-id><pub-id pub-id-type="pmid">15003169</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Syed</surname> <given-names>A</given-names></name><name><surname>Baker</surname> <given-names>PM</given-names></name><name><surname>Ragozzino</surname> <given-names>ME</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Pedunculopontine tegmental nucleus lesions impair probabilistic reversal learning by reducing sensitivity to positive reward feedback</article-title><source>Neurobiology of Learning and Memory</source><volume>131</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1016/j.nlm.2016.03.010</pub-id><pub-id pub-id-type="pmid">26976089</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanabe</surname> <given-names>LM</given-names></name><name><surname>Liang</surname> <given-names>CC</given-names></name><name><surname>Dauer</surname> <given-names>WT</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Neuronal Nuclear Membrane Budding Occurs during a Developmental Window Modulated by Torsin Paralogs</article-title><source>Cell Reports</source><volume>16</volume><fpage>3322</fpage><lpage>3333</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2016.08.044</pub-id><pub-id pub-id-type="pmid">27653693</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unal</surname> <given-names>CT</given-names></name><name><surname>Golowasch</surname> <given-names>JP</given-names></name><name><surname>Zaborszky</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Adult mouse basal forebrain harbors two distinct cholinergic populations defined by their electrophysiology</article-title><source>Frontiers in Behavioral Neuroscience</source><volume>6</volume><elocation-id>21</elocation-id><pub-id pub-id-type="doi">10.3389/fnbeh.2012.00021</pub-id><pub-id pub-id-type="pmid">22586380</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Virk</surname> <given-names>MS</given-names></name><name><surname>Sagi</surname> <given-names>Y</given-names></name><name><surname>Medrihan</surname> <given-names>L</given-names></name><name><surname>Leung</surname> <given-names>J</given-names></name><name><surname>Kaplitt</surname> <given-names>MG</given-names></name><name><surname>Greengard</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Opposing roles for serotonin in cholinergic neurons of the ventral and dorsal striatum</article-title><source>Proceedings of the National Academy of Sciences</source><volume>113</volume><fpage>734</fpage><lpage>739</lpage><pub-id pub-id-type="doi">10.1073/pnas.1524183113</pub-id><pub-id pub-id-type="pmid">26733685</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>HL</given-names></name><name><surname>Morales</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Pedunculopontine and laterodorsal tegmental nuclei contain distinct populations of cholinergic, glutamatergic and GABAergic neurons in the rat</article-title><source>European Journal of Neuroscience</source><volume>29</volume><fpage>340</fpage><lpage>358</lpage><pub-id pub-id-type="doi">10.1111/j.1460-9568.2008.06576.x</pub-id><pub-id pub-id-type="pmid">19200238</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiao</surname> <given-names>C</given-names></name><name><surname>Cho</surname> <given-names>JR</given-names></name><name><surname>Zhou</surname> <given-names>C</given-names></name><name><surname>Treweek</surname> <given-names>JB</given-names></name><name><surname>Chan</surname> <given-names>K</given-names></name><name><surname>McKinney</surname> <given-names>SL</given-names></name><name><surname>Yang</surname> <given-names>B</given-names></name><name><surname>Gradinaru</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Cholinergic Mesopontine Signals Govern Locomotion and Reward through Dissociable Midbrain Pathways</article-title><source>Neuron</source><volume>90</volume><fpage>333</fpage><lpage>347</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.03.028</pub-id><pub-id pub-id-type="pmid">27100197</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yarom</surname> <given-names>O</given-names></name><name><surname>Cohen</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Putative cholinergic interneurons in the ventral and dorsal regions of the striatum have distinct roles in a two choice alternative association task</article-title><source>Frontiers in Systems Neuroscience</source><volume>5</volume><elocation-id>36</elocation-id><pub-id pub-id-type="doi">10.3389/fnsys.2011.00036</pub-id><pub-id pub-id-type="pmid">21660109</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Zaborszky</surname> <given-names>L</given-names></name><name><surname>van den Pol</surname> <given-names>A</given-names></name><name><surname>Gyengesi</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2012">2012</year><chapter-title>The basal forebrain cholinergic projection system in mice</chapter-title><source>The Mouse Nervous System</source><fpage>684</fpage><lpage>714</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-369497-3.10028-7</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zweig</surname> <given-names>RM</given-names></name><name><surname>Hedreen</surname> <given-names>JC</given-names></name><name><surname>Jankel</surname> <given-names>WR</given-names></name><name><surname>Casanova</surname> <given-names>MF</given-names></name><name><surname>Whitehouse</surname> <given-names>PJ</given-names></name><name><surname>Price</surname> <given-names>DL</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Pathology in brainstem regions of individuals with primary dystonia</article-title><source>Neurology</source><volume>38</volume><fpage>702</fpage><lpage>706</lpage><pub-id pub-id-type="doi">10.1212/WNL.38.5.702</pub-id><pub-id pub-id-type="pmid">3362365</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="SA1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.36691.023</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Ptáček</surname><given-names>Louis J</given-names></name><role>Reviewing Editor</role><aff><institution>University of California, San Francisco</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Ptáček</surname><given-names>Louis J</given-names></name><role>Reviewer</role><aff><institution>University of California, San Francisco</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.</p></boxed-text><p>Thank you for submitting your article &quot;A cell autonomous torsinA requirement for cholinergic neuron survival and motor control&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, including Louis J Ptáček as the Reviewing Editor and Reviewer #1, and the evaluation has been overseen by a Senior Editor.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission..</p><p>Summary:</p><p>In a previous study (Pappas et al., 2015), Pappas et al. made the important findings that deletion of torsinA in embryonic progenitors of forebrain cholinergic and GABAergic neurons caused selective degeneration of dorsal striatal cholinergic interneurons, and that the loss of dorsal striatal cholinergic interneurons was sufficient to cause dystonic-like twisting movements that emerged during juvenile CNS maturation.</p><p>The original paper already described selective loss of ChI. Dlx5/6 is far broader in its expression than ChAT Cre – it encompasses all forebrain inhibitory neurons and cholinergic neurons. So it would have been hard to know if the ChI degeneration was due to loss of all other interneurons or if was cell-intrinsic, so here they show it is specific to cholinergic. It also associated motor dysfunction with the ChI loss – and a central point of that paper was that cholinergic cells <italic>were</italic> responsible since motor defects were rescued by cholinergic pharmacology. Given this knowledge, the new data showing torsinA deletion from cholinergic neurons causes motor dysfunction is less interesting. In other work, the authors defined a postnatal developmental window where neurons were most susceptible to torsinA loss. At least, this was the take home message of their study (Tanabe, 2016). Given this, there is some worry about whether the difference in neuronal vulnerability relates to the speed that torsinA is lost after Cre-mediated deletion. We don't know that Cre expression is the same across all ChI, in terms of levels or timing. We also don't know if torsinA half-life is the same in all ChI – and likely is not and may depend on cellular metabolic activity, etc. It doesn't appear that we have a good handle on torsinA half-life in general, and it's potentially quite long lived. Also, what role might torsinB have in reducing vulnerability in some cells? The most important conclusion, that the phenotype is indeed from cholinergic cells and not all inhibitory neurons in striatum, is the most notable part of this manuscript. It is amazing that a very small percentage of neurons in the dorsal striatum can have such dramatic and quite specific effects on behavior in a disease model.</p><p>While the data here (and their other papers) are convincing, we feel it is important to completely exclude the possibility that selective neuronal vulnerability (that they focus on here) derives from technical vs. disease-relevant biology. The reviewers wanted to be sure that ChAT-Cre is not expressed earlier or more broadly than expected. The story is more exciting if associated with a satisfactory explanation of differential vulnerability. Also, it is essential to ensure that differential vulnerability is not due to differences in completeness of torsinA deletion in different cell types. Are reagents available to do this in a timely manner? It is important to compare efficiency of deletion in both KOs, although the key finding is that ChAT alone reproduces the broad Dlx5/6 KO. They can do in situ to evaluate effectiveness of KO.</p><p>Essential revisions:</p><p>1) It is not clear why some populations of cholinergic neurons are more vulnerable to torsinA deficiency. Although this is a hard question to address, inclusion of other prominent cholinergic neurons and contrasting their cellular properties may provide some clues. The manuscript gives the impression that cholinergic neurons related to motor functions are more vulnerable. This seems to be a circular argument (not a mechanistic one).</p><p>2) In PPN and LDT, both cholinergic neurons and NeuN+ cells were counted. It is surprising that there was loss of cholinergic neurons but not NeuN+ cells. It is likely that noise in the data diluted the signal in counting NeuN+ cells. However, it is also possible that loss of cholinergic neurons is due to loss of cholinergic marker expression. This needs more data and/or explanation.</p><p>3) The motor symptom differences between ChAT-CKO and Dlx-CKO were not explained clearly. It will be helpful to list the main differences between the two manipulations at both the circuit level and behavioral level to give more insights into the phenotypic differences and functional implications.</p><p>4) The new information is limited to showing that ChI loss occurs because of torsinA loss in the ChI themselves. This does not answer whether different ChI populations have different molecular profiles that render them more or less sensitive to torsinA loss (so that dorsal vs. ventral ChI might be considered as different cell types). Alternatively, it might still be that the nature of ChI connectivity differs between striatal regions so that only one set of cells requires torsinA (for example if degeneration depends on excitotoxicity, and ChI in dorsal striatum receive more direct glutamatergic inputs).</p><p>5) A technical issue is whether it is 100% clear that the genetic technology causes the exact same loss of torsinA in the two populations. The manuscript shows Cre expression across the striatum, but this is not synonymous with a time course of how torsinA protein is lost from the two populations. Is it possible that dorsal neurons are more sensitive because they more rapidly lose torsinA protein? This needs very careful controls given it is central to their conclusion that the regional specificity has physiological relevance.</p><p>6) I am also left wondering how ChI degeneration relates to other mechanisms shown by the group like abnormal nuclear pore complexes, or torsinB expression. Do these have any role in the selective vulnerability? Further, is there a link between ChI vulnerability and that of the deep cerebellar nuclei and sensorimotor cortical neurons that they showed are selectively lost when torsinA is deleted across the brain (Liang, 2014).</p></body></sub-article><sub-article article-type="reply" id="SA2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.36691.024</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) It is not clear why some populations of cholinergic neurons are more vulnerable to torsinA deficiency. Although this is a hard question to address, inclusion of other prominent cholinergic neurons and contrasting their cellular properties may provide some clues. The manuscript gives the impression that cholinergic neurons related to motor functions are more vulnerable. This seems to be a circular argument (not a mechanistic one).</p></disp-quote><p>We appreciate this comment and have removed all statements implying that connections to motor function render neurons more vulnerable. We also include a new table comparing the cellular properties (neuronal class, firing properties, efferent projections, afferent input, birth dates, embryonic origins, time of first ChAT expression, and vulnerability to cell death) between dorsal striatum, ventral striatum, basal forebrain, PPN/LDT, and primary motor neurons (Table 2). Although obvious patterns between vulnerable populations do not immediately emerge, we believe that this information will be valuable for future studies stimulated by our new findings, aimed at further advancing understanding of the mechanisms of selective vulnerability.</p><disp-quote content-type="editor-comment"><p>2) In PPN and LDT, both cholinergic neurons and NeuN+ cells were counted. It is surprising that there was loss of cholinergic neurons but not NeuN+ cells. It is likely that noise in the data diluted the signal in counting NeuN+ cells. However, it is also possible that loss of cholinergic neurons is due to loss of cholinergic marker expression. This needs more data and/or explanation.</p></disp-quote><p>We are also surprised that NeuN+ cell numbers were not different in the LDT and PPN and agree that there are other potential explanations for the ChAT+ cell numbers, including reduction of ChAT expression without frank cell loss.</p><p>Several anatomical studies demonstrate that non-cholinergic cell types in the PPN and LDT greatly outnumber cholinergic neurons. There are at least twice as many GABAergic as cholinergic neurons (Mena-Segovia et al., 2009), and glutamatergic neurons are at least as abundant as GABAergic, or present at even higher numbers (Martinez-Gonzalez et al., 2012; Wang and Morales, 2009). Indeed, in the rostral PPN, the density of GABAergic neurons is more than 5 times higher than cholinergic neurons (Martinez-Gonzalez et al., 2011). Because cholinergic neurons represent a small minority of cells in the PPN and LDT, we believe it most likely that reduction of this small population of cells was ‘lost in the noise’ of the overall NeuN+ cell counts, as suggested.</p><p>To specifically address the issue of cell loss versus ChAT downregulation, we attempted to define alternative markers of brainstem cholinergic neuron populations. We performed a series of studies examining P75 and VAChT as additional markers. Unfortunately, these molecules did not reliably or reproducibly mark PPN and LDT cell bodies. P75 was present in synaptic inputs to cholinergic brainstem neurons but not in PPN or LDT neurons themselves. VAChT appeared punctate throughout the region, but cell soma expression was not clear or sufficiently defined for stereological assessment. Unlike striatal ChI, cholinergic brainstem neurons are not uniformly larger than other intermingled cell populations, preventing us from using cell size as a proxy (as previously done for forebrain populations (Pappas et al., 2015)). We therefore cannot provide additional evidence to support the presence of cholinergic brainstem neurodegeneration at this time.</p><p>In our revised manuscript, we highlight these valuable new points. We make clear the relative numbers of cholinergic and non-cholinergic cells in these brainstem nuclei and point out that our findings in the brainstem may reflect downregulation of ChAT as opposed to cell loss (as clearly occurs in striatum). Importantly, whether these cells “only” lose ChAT expression, or degenerate, our findings are the first to demonstrate a cell autonomous torsinA requirement for brainstem cholinergic neuron function.</p><disp-quote content-type="editor-comment"><p>3) The motor symptom differences between ChAT-CKO and Dlx-CKO were not explained clearly. It will be helpful to list the main differences between the two manipulations at both the circuit level and behavioral level to give more insights into the phenotypic differences and functional implications.</p></disp-quote><p>We appreciate this feedback. We have now generated a table outlining all known motor features of Dlx-CKO and ChAT-CKO mice (Table 1), which will greatly facilitate for the reader a direct comparison between the models.</p><disp-quote content-type="editor-comment"><p>4) The new information is limited to showing that ChI loss occurs because of torsinA loss in the ChI themselves. This does not answer whether different ChI populations have different molecular profiles that render them more or less sensitive to torsinA loss (so that dorsal vs. ventral ChI might be considered as different cell types). Alternatively, it might still be that the nature of ChI connectivity differs between striatal regions so that only one set of cells requires torsinA (for example if degeneration depends on excitotoxicity, and ChI in dorsal striatum receive more direct glutamatergic inputs).</p></disp-quote><p>We agree that the major mechanistic finding of this paper is that torsinA loss in ChI themselves causes cell death, rather than via non-cell autonomous mechanisms of surrounding torsinA deficient neurons. This result is striking and represents an important advance considering the subregion specificity of the loss (to the most dorsal “motor” aspects of dorsal striatum) is driven by a cell autonomous effect of torsinA in a population of cells typically considered “uniform.” The intriguing and important question raised by the reviewers speaks to the interesting issues raised by our novel finding: do multiple unique ChI cell types exist (one vulnerable, others spared), or do connectivity differences drive differential susceptibility to torsinA loss of function.</p><p>There is precedent for either possibility (or both). While often considered a single neuronal class, dorsal and ventral striatal ChI exhibit significant differences in morphology, regulation, and receptor expression (reviewed in (Gonzales and Smith, 2015)), as well as different responses to serotonin input (Virk et al., 2016) and differential firing patterns during some motor behavioral tasks (Yarom and Cohen, 2011). These differences are consistent with the existence of multiple ChI subclasses, though it is important to note that the “ventral” population in our manuscript is the ventral part of the dorsal striatum, not the nucleus accumbens. In our revised manuscript we have better highlighted this literature, which we believe – together with our new findings – will stimulate additional work in this interesting area.</p><p>It is also possible that the unique pattern of afferent inputs could contribute to the striking pattern of subregion vulnerability we observe, as thalamostriatal and corticostriatal input is highly topographic (Alexander et al., 1986; Smith et al., 2004).</p><p>We think it most likely that a combination of factors plays a role in the differential susceptibility of different cholinergic neuronal populations, including their molecular profiles (e.g., protective factors in some neurons, susceptibility factors in others), the response to differential afferent inputs, and their inherent physiological properties. Our new findings point to future experiments comparing vulnerable and invulnerable populations at multiple mechanistic levels that will be required to elucidate the mechanism(s) responsible differential vulnerability. These important questions will require significant experimental effort – likely years worth of work – which we believe is beyond the scope of this manuscript. However, to help stimulate future work, we have added a short discussion of different possible explanations for differential susceptibility to the Discussion section.</p><disp-quote content-type="editor-comment"><p>5) A technical issue is whether it is 100% clear that the genetic technology causes the exact same loss of torsinA in the two populations. The manuscript shows Cre expression across the striatum, but this is not synonymous with a time course of how torsinA protein is lost from the two populations. Is it possible that dorsal neurons are more sensitive because they more rapidly lose torsinA protein? This needs very careful controls given it is central to their conclusion that the regional specificity has physiological relevance.</p></disp-quote><p>We appreciate the reviewer raising this very important point, which we had not previously systematically examined. To further explore this issue, we assessed torsinA levels in cholinergic neurons at P0 in ChAT-CKO and Cre negative control mice (the same time for which we document uniform Cre expression). Despite unambiguous prenatal Cre expression (Figure 1—figure supplement 1), our new data demonstrate that at least 50% of torsinA remained in cholinergic neurons at P0 using the semi-quantitative measurement of fluorescence intensity. To determine whether, following Cre-recombination, the levels of torsinA loss correspond to cell loss, we compared the levels of torsinA immunofluorescence in dorsal striatal (vulnerable) and ventral striatal (invulnerable) ChI at P0. Surprisingly, the invulnerable ventral striatal ChI exhibited a significantly greater decrease of torsinA (~48% decrement) compared to vulnerable dorsal striatal ChI population (~18% decrement) (Two-way ANOVA with post-hoc Sidak’s multiple comparisons test. ChAT-CKO dorsal vs ventral p&lt;0.0002. Full details in legend to Figure 1—figure supplement 4). We also assessed torsinA levels in basal forebrain cholinergic projection neurons, which are spared in all DYT1 models assessed. Basal forebrain cholinergic neurons from ChAT-CKO mice exhibited an ~51% of loss of torsinA (compared to control; p&lt;0.0001, Welch’s t-test; Figure 1—figure supplement 5), similar to the levels in ventral ChI. Considered together, these data argue against the possibility that more rapid loss of torsinA from dorsal striatal neurons contributes to their selective degeneration. These findings also eliminate the possibility of a technical artifact whereby Cre recombination occurs selectively in dorsal ChI.</p><disp-quote content-type="editor-comment"><p>6) I am also left wondering how ChI degeneration relates to other mechanisms shown by the group like abnormal nuclear pore complexes, or torsinB expression. Do these have any role in the selective vulnerability? Further, is there a link between ChI vulnerability and that of the deep cerebellar nuclei and sensorimotor cortical neurons that they showed are selectively lost when torsinA is deleted across the brain (Liang, 2014).</p></disp-quote><p>We agree that linking previously described torsinA loss-of-function mediated phenotypes (nuclear pore complex abnormalities or ubiquitin accumulation (Liang et al., 2014; Pappas et al., 2018) is of interest and could help to advance a theme underlying selective cell vulnerability. Interestingly, the events occurring in striatal ChI may be distinct from those previously defined (including in DCN and sensorimotor cortex). In contrast to these non-cholinergic neuronal populations, we do not observe nuclear pore complex or ubiquitin abnormalities in striatal ChIs (Pappas et al., 2018). As noted, our prior work a links torsinB levels to the developmental nuclear envelope phenotypes (Kim et al., 2010; Tanabe et al., 2016), but that work did not directly address the relationship between torsinB and cell death. We have used laser capture microdissection to examine the levels of torsinB mRNA in wild type and torsinA null striatal ChI; we find no difference in torsinB levels between these conditions so think it is unlikely to be playing a role in this specific context (we would be happy to include these data if the reviewers deem it essential). As noted in our response to the prior question, these new findings are the first to identify a cell autonomous role for torsinA in a subpopulation of striatal ChI critical for motor function (and which as strongly implicated in the disease). This new finding represents a significant advance in understanding the mechanism of selective ChI loss reported in our original <italic>eLife</italic> publication, setting the stage for future studies that we believe to be beyond the scope of the current manuscript.</p></body></sub-article></article>